US20180310866A1 - Mental health assessment method and kiosk-based system for implementation - Google Patents
Mental health assessment method and kiosk-based system for implementation Download PDFInfo
- Publication number
- US20180310866A1 US20180310866A1 US16/030,213 US201816030213A US2018310866A1 US 20180310866 A1 US20180310866 A1 US 20180310866A1 US 201816030213 A US201816030213 A US 201816030213A US 2018310866 A1 US2018310866 A1 US 2018310866A1
- Authority
- US
- United States
- Prior art keywords
- subject
- disorder
- response
- medical history
- health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 135
- 230000004630 mental health Effects 0.000 title claims description 28
- 230000003542 behavioural effect Effects 0.000 claims abstract description 165
- 230000004044 response Effects 0.000 claims abstract description 101
- 230000006996 mental state Effects 0.000 claims abstract description 64
- 239000011159 matrix material Substances 0.000 claims abstract description 7
- 230000036541 health Effects 0.000 claims description 172
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 129
- 208000028173 post-traumatic stress disease Diseases 0.000 claims description 22
- 238000011282 treatment Methods 0.000 claims description 14
- 238000012552 review Methods 0.000 claims description 13
- 208000011117 substance-related disease Diseases 0.000 claims description 12
- 208000020925 Bipolar disease Diseases 0.000 claims description 11
- 201000009032 substance abuse Diseases 0.000 claims description 5
- 231100000736 substance abuse Toxicity 0.000 claims description 4
- 208000035475 disorder Diseases 0.000 description 111
- 208000020016 psychiatric disease Diseases 0.000 description 44
- 210000003169 central nervous system Anatomy 0.000 description 34
- 239000003814 drug Substances 0.000 description 29
- 230000003340 mental effect Effects 0.000 description 29
- 229940079593 drug Drugs 0.000 description 28
- 208000024891 symptom Diseases 0.000 description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- 208000028017 Psychotic disease Diseases 0.000 description 25
- 208000011580 syndromic disease Diseases 0.000 description 23
- 230000006399 behavior Effects 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- 208000020401 Depressive disease Diseases 0.000 description 16
- 206010012289 Dementia Diseases 0.000 description 14
- 208000015114 central nervous system disease Diseases 0.000 description 14
- 208000022821 personality disease Diseases 0.000 description 14
- 208000019022 Mood disease Diseases 0.000 description 13
- 238000005259 measurement Methods 0.000 description 13
- 230000036651 mood Effects 0.000 description 13
- 201000000980 schizophrenia Diseases 0.000 description 13
- 208000019901 Anxiety disease Diseases 0.000 description 11
- 230000007177 brain activity Effects 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 230000035882 stress Effects 0.000 description 11
- 206010026749 Mania Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 238000012216 screening Methods 0.000 description 10
- 208000017194 Affective disease Diseases 0.000 description 9
- 241000208125 Nicotiana Species 0.000 description 9
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 206010015037 epilepsy Diseases 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 208000007848 Alcoholism Diseases 0.000 description 8
- 208000023105 Huntington disease Diseases 0.000 description 8
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 8
- 208000002851 paranoid schizophrenia Diseases 0.000 description 8
- 239000003981 vehicle Substances 0.000 description 8
- 206010010904 Convulsion Diseases 0.000 description 7
- 208000024254 Delusional disease Diseases 0.000 description 7
- 208000027534 Emotional disease Diseases 0.000 description 7
- 208000018737 Parkinson disease Diseases 0.000 description 7
- 231100000430 skin reaction Toxicity 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 208000024827 Alzheimer disease Diseases 0.000 description 6
- 206010019468 Hemiplegia Diseases 0.000 description 6
- 208000016285 Movement disease Diseases 0.000 description 6
- 206010029333 Neurosis Diseases 0.000 description 6
- 230000001154 acute effect Effects 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 230000007357 depressive behavior Effects 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 230000001667 episodic effect Effects 0.000 description 6
- 208000015122 neurodegenerative disease Diseases 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 230000001314 paroxysmal effect Effects 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 206010000117 Abnormal behaviour Diseases 0.000 description 5
- 206010003694 Atrophy Diseases 0.000 description 5
- 206010003805 Autism Diseases 0.000 description 5
- 208000020706 Autistic disease Diseases 0.000 description 5
- 208000014644 Brain disease Diseases 0.000 description 5
- 208000027691 Conduct disease Diseases 0.000 description 5
- 208000016192 Demyelinating disease Diseases 0.000 description 5
- 206010012374 Depressed mood Diseases 0.000 description 5
- 208000014094 Dystonic disease Diseases 0.000 description 5
- 208000002877 Epileptic Syndromes Diseases 0.000 description 5
- 208000027520 Somatoform disease Diseases 0.000 description 5
- 230000036506 anxiety Effects 0.000 description 5
- 230000037444 atrophy Effects 0.000 description 5
- 208000029560 autism spectrum disease Diseases 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000008451 emotion Effects 0.000 description 5
- 208000015238 neurotic disease Diseases 0.000 description 5
- 230000009885 systemic effect Effects 0.000 description 5
- 206010003591 Ataxia Diseases 0.000 description 4
- 206010010144 Completed suicide Diseases 0.000 description 4
- 206010012559 Developmental delay Diseases 0.000 description 4
- 206010013654 Drug abuse Diseases 0.000 description 4
- 208000032274 Encephalopathy Diseases 0.000 description 4
- 208000027626 Neurocognitive disease Diseases 0.000 description 4
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 description 4
- 208000021155 Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 206010033892 Paraplegia Diseases 0.000 description 4
- 206010037714 Quadriplegia Diseases 0.000 description 4
- 208000010112 Spinocerebellar Degenerations Diseases 0.000 description 4
- 208000006011 Stroke Diseases 0.000 description 4
- 206010001584 alcohol abuse Diseases 0.000 description 4
- 208000025746 alcohol use disease Diseases 0.000 description 4
- 208000018300 basal ganglia disease Diseases 0.000 description 4
- 201000007293 brain stem infarction Diseases 0.000 description 4
- 206010008129 cerebral palsy Diseases 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 235000018823 dietary intake Nutrition 0.000 description 4
- 208000024732 dysthymic disease Diseases 0.000 description 4
- 201000009028 early myoclonic encephalopathy Diseases 0.000 description 4
- 230000002996 emotional effect Effects 0.000 description 4
- 231100001261 hazardous Toxicity 0.000 description 4
- 208000024714 major depressive disease Diseases 0.000 description 4
- 208000005264 motor neuron disease Diseases 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 230000000626 neurodegenerative effect Effects 0.000 description 4
- 230000008520 organization Effects 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 230000001769 paralizing effect Effects 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 238000001671 psychotherapy Methods 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 3
- 208000032194 Acute haemorrhagic leukoencephalitis Diseases 0.000 description 3
- 208000012239 Developmental disease Diseases 0.000 description 3
- 208000019454 Feeding and Eating disease Diseases 0.000 description 3
- 201000001916 Hypochondriasis Diseases 0.000 description 3
- 206010021750 Infantile Spasms Diseases 0.000 description 3
- 208000004552 Lacunar Stroke Diseases 0.000 description 3
- 208000009829 Lewy Body Disease Diseases 0.000 description 3
- 201000002832 Lewy body dementia Diseases 0.000 description 3
- 208000000060 Migraine with aura Diseases 0.000 description 3
- 208000012202 Pervasive developmental disease Diseases 0.000 description 3
- 206010034912 Phobia Diseases 0.000 description 3
- 208000033042 Somatoform disorder cardiovascular Diseases 0.000 description 3
- 201000004810 Vascular dementia Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 208000003554 absence epilepsy Diseases 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 3
- 229940049706 benzodiazepine Drugs 0.000 description 3
- 239000012867 bioactive agent Substances 0.000 description 3
- 208000022266 body dysmorphic disease Diseases 0.000 description 3
- 208000029028 brain injury Diseases 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000001149 cognitive effect Effects 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 208000010118 dystonia Diseases 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 208000013403 hyperactivity Diseases 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000004807 localization Effects 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 235000020786 mineral supplement Nutrition 0.000 description 3
- 229940029985 mineral supplement Drugs 0.000 description 3
- 201000006417 multiple sclerosis Diseases 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- 208000009157 neurocirculatory asthenia Diseases 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 230000002085 persistent effect Effects 0.000 description 3
- 208000019899 phobic disease Diseases 0.000 description 3
- 201000002241 progressive bulbar palsy Diseases 0.000 description 3
- 230000003252 repetitive effect Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 201000008417 spastic hemiplegia Diseases 0.000 description 3
- 208000002320 spinal muscular atrophy Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 208000016686 tic disease Diseases 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 230000004304 visual acuity Effects 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000019195 vitamin supplement Nutrition 0.000 description 3
- 208000007415 Anhedonia Diseases 0.000 description 2
- 206010002942 Apathy Diseases 0.000 description 2
- 208000036640 Asperger disease Diseases 0.000 description 2
- 201000006062 Asperger syndrome Diseases 0.000 description 2
- 206010003594 Ataxia telangiectasia Diseases 0.000 description 2
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 2
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 2
- 206010006550 Bulimia nervosa Diseases 0.000 description 2
- 241000218236 Cannabis Species 0.000 description 2
- 201000001913 Childhood absence epilepsy Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 208000032170 Congenital Abnormalities Diseases 0.000 description 2
- 206010011971 Decreased interest Diseases 0.000 description 2
- 206010012218 Delirium Diseases 0.000 description 2
- 206010012305 Demyelination Diseases 0.000 description 2
- 208000001495 Disorganized Schizophrenia Diseases 0.000 description 2
- 206010049669 Dyscalculia Diseases 0.000 description 2
- 206010049096 Dysmorphophobia Diseases 0.000 description 2
- 208000030814 Eating disease Diseases 0.000 description 2
- 208000027776 Extrapyramidal disease Diseases 0.000 description 2
- 208000026097 Factitious disease Diseases 0.000 description 2
- 208000024412 Friedreich ataxia Diseases 0.000 description 2
- 201000011240 Frontotemporal dementia Diseases 0.000 description 2
- 208000001613 Gambling Diseases 0.000 description 2
- 208000011688 Generalised anxiety disease Diseases 0.000 description 2
- 208000034308 Grand mal convulsion Diseases 0.000 description 2
- 208000004547 Hallucinations Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010021212 Ideas of reference Diseases 0.000 description 2
- 208000006136 Leigh Disease Diseases 0.000 description 2
- 206010061285 Mental disorder due to a general medical condition Diseases 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- 206010027926 Monoplegia Diseases 0.000 description 2
- 206010028570 Myelopathy Diseases 0.000 description 2
- 208000036572 Myoclonic epilepsy Diseases 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- 208000000224 Night Terrors Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 206010033864 Paranoia Diseases 0.000 description 2
- 208000027099 Paranoid disease Diseases 0.000 description 2
- 206010034010 Parkinsonism Diseases 0.000 description 2
- 241001482237 Pica Species 0.000 description 2
- 208000000609 Pick Disease of the Brain Diseases 0.000 description 2
- 201000009916 Postpartum depression Diseases 0.000 description 2
- 208000032319 Primary lateral sclerosis Diseases 0.000 description 2
- 208000006289 Rett Syndrome Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010041250 Social phobia Diseases 0.000 description 2
- 206010041347 Somnambulism Diseases 0.000 description 2
- 208000003954 Spinal Muscular Atrophies of Childhood Diseases 0.000 description 2
- 208000009415 Spinocerebellar Ataxias Diseases 0.000 description 2
- 208000003028 Stuttering Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 206010042928 Syringomyelia Diseases 0.000 description 2
- 206010046298 Upper motor neurone lesion Diseases 0.000 description 2
- 206010048010 Withdrawal syndrome Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 208000012826 adjustment disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000003109 amnesic effect Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 208000024823 antisocial personality disease Diseases 0.000 description 2
- 201000007201 aphasia Diseases 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 208000004711 cerebrospinal fluid leak Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229960003920 cocaine Drugs 0.000 description 2
- 208000010877 cognitive disease Diseases 0.000 description 2
- 230000010485 coping Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 208000010934 demyelinating disease of central nervous system Diseases 0.000 description 2
- 230000003001 depressive effect Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000014632 disordered eating Nutrition 0.000 description 2
- 208000018459 dissociative disease Diseases 0.000 description 2
- 206010013932 dyslexia Diseases 0.000 description 2
- 235000005686 eating Nutrition 0.000 description 2
- 238000002635 electroconvulsive therapy Methods 0.000 description 2
- 231100000305 environmental exposure data Toxicity 0.000 description 2
- 201000006517 essential tremor Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000005021 gait Effects 0.000 description 2
- 208000029364 generalized anxiety disease Diseases 0.000 description 2
- 230000037308 hair color Effects 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- 230000000004 hemodynamic effect Effects 0.000 description 2
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 206010023461 kleptomania Diseases 0.000 description 2
- 201000010901 lateral sclerosis Diseases 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 206010052787 migraine without aura Diseases 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 230000004770 neurodegeneration Effects 0.000 description 2
- 208000008795 neuromyelitis optica Diseases 0.000 description 2
- 239000002767 noradrenalin uptake inhibitor Substances 0.000 description 2
- 208000030459 obsessive-compulsive personality disease Diseases 0.000 description 2
- 210000004789 organ system Anatomy 0.000 description 2
- 208000019906 panic disease Diseases 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000036544 posture Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 201000002212 progressive supranuclear palsy Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000001747 pupil Anatomy 0.000 description 2
- 201000004645 pyromania Diseases 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 230000004043 responsiveness Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 230000022676 rumination Effects 0.000 description 2
- 208000022610 schizoaffective disease Diseases 0.000 description 2
- 229940124834 selective serotonin reuptake inhibitor Drugs 0.000 description 2
- 239000012896 selective serotonin reuptake inhibitor Substances 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- 235000011888 snacks Nutrition 0.000 description 2
- 201000008425 spastic quadriplegia Diseases 0.000 description 2
- 208000031409 spastic quadriplegic cerebral palsy Diseases 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 238000013456 study Methods 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 description 1
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- KTGRHKOEFSJQNS-BDQAORGHSA-N (1s)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3h-2-benzofuran-5-carbonitrile;oxalic acid Chemical compound OC(=O)C(O)=O.C1([C@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 KTGRHKOEFSJQNS-BDQAORGHSA-N 0.000 description 1
- WSEQXVZVJXJVFP-HXUWFJFHSA-N (R)-citalopram Chemical compound C1([C@@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-HXUWFJFHSA-N 0.000 description 1
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 description 1
- ZEUITGRIYCTCEM-KRWDZBQOSA-N (S)-duloxetine Chemical compound C1([C@@H](OC=2C3=CC=CC=C3C=CC=2)CCNC)=CC=CS1 ZEUITGRIYCTCEM-KRWDZBQOSA-N 0.000 description 1
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 description 1
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 description 1
- 206010000346 Acalculia Diseases 0.000 description 1
- 206010000605 Acrophobia Diseases 0.000 description 1
- 108060003345 Adrenergic Receptor Proteins 0.000 description 1
- 102000017910 Adrenergic receptor Human genes 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000008811 Agoraphobia Diseases 0.000 description 1
- 208000036022 Alpers' disease Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 208000000103 Anorexia Nervosa Diseases 0.000 description 1
- 206010002820 Antisocial behaviour Diseases 0.000 description 1
- 206010002859 Anxiety disorder due to a general medical condition Diseases 0.000 description 1
- 206010003628 Atonic seizures Diseases 0.000 description 1
- 208000027448 Attention Deficit and Disruptive Behavior disease Diseases 0.000 description 1
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000034577 Benign intracranial hypertension Diseases 0.000 description 1
- 206010005885 Blunted affect Diseases 0.000 description 1
- 208000002381 Brain Hypoxia Diseases 0.000 description 1
- 208000024806 Brain atrophy Diseases 0.000 description 1
- 201000002345 Brain compression Diseases 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- 206010006362 Brief psychotic disorder, with postpartum onset Diseases 0.000 description 1
- 206010068597 Bulbospinal muscular atrophy congenital Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000001573 Cataplexy Diseases 0.000 description 1
- 208000009810 Catatonic Schizophrenia Diseases 0.000 description 1
- 206010008025 Cerebellar ataxia Diseases 0.000 description 1
- 206010061445 Cerebral cyst Diseases 0.000 description 1
- 206010008748 Chorea Diseases 0.000 description 1
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 1
- 208000033647 Classic progressive supranuclear palsy syndrome Diseases 0.000 description 1
- 206010009244 Claustrophobia Diseases 0.000 description 1
- GDLIGKIOYRNHDA-UHFFFAOYSA-N Clomipramine Chemical compound C1CC2=CC=C(Cl)C=C2N(CCCN(C)C)C2=CC=CC=C21 GDLIGKIOYRNHDA-UHFFFAOYSA-N 0.000 description 1
- 208000006561 Cluster Headache Diseases 0.000 description 1
- 208000022497 Cocaine-Related disease Diseases 0.000 description 1
- 208000033001 Complex partial seizures Diseases 0.000 description 1
- 208000032106 Complicated migraine Diseases 0.000 description 1
- 206010010252 Concentric sclerosis Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000032065 Convulsion neonatal Diseases 0.000 description 1
- 208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 1
- 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 1
- 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 1
- 206010012225 Delirium tremens Diseases 0.000 description 1
- 206010012239 Delusion Diseases 0.000 description 1
- 208000032538 Depersonalisation Diseases 0.000 description 1
- 206010012422 Derealisation Diseases 0.000 description 1
- HCYAFALTSJYZDH-UHFFFAOYSA-N Desimpramine Chemical compound C1CC2=CC=CC=C2N(CCCNC)C2=CC=CC=C21 HCYAFALTSJYZDH-UHFFFAOYSA-N 0.000 description 1
- 208000019246 Developmental coordination disease Diseases 0.000 description 1
- 208000004986 Diffuse Cerebral Sclerosis of Schilder Diseases 0.000 description 1
- 206010013033 Diplegia Diseases 0.000 description 1
- 206010013142 Disinhibition Diseases 0.000 description 1
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 description 1
- 208000026331 Disruptive, Impulse Control, and Conduct disease Diseases 0.000 description 1
- 208000025967 Dissociative Identity disease Diseases 0.000 description 1
- 208000035713 Dissociative fugue Diseases 0.000 description 1
- 206010013486 Distractibility Diseases 0.000 description 1
- 206010013496 Disturbance in attention Diseases 0.000 description 1
- 102000015554 Dopamine receptor Human genes 0.000 description 1
- 108050004812 Dopamine receptor Proteins 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 208000016753 Early-onset cerebellar ataxia with retained tendon reflexes Diseases 0.000 description 1
- 206010014557 Emotional poverty Diseases 0.000 description 1
- 208000000271 Encopresis Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000024658 Epilepsy syndrome Diseases 0.000 description 1
- 208000016132 Epilepsy with myoclonic absences Diseases 0.000 description 1
- 241001539473 Euphoria Species 0.000 description 1
- 206010015535 Euphoric mood Diseases 0.000 description 1
- 208000021584 Expressive language disease Diseases 0.000 description 1
- 208000018460 Feeding disease Diseases 0.000 description 1
- 206010016374 Feelings of worthlessness Diseases 0.000 description 1
- 208000001836 Firesetting Behavior Diseases 0.000 description 1
- 206010016759 Flat affect Diseases 0.000 description 1
- 208000013279 Foix-Alajouanine syndrome Diseases 0.000 description 1
- 208000001914 Fragile X syndrome Diseases 0.000 description 1
- 208000007223 Gerstmann syndrome Diseases 0.000 description 1
- 206010018671 Grandiosity Diseases 0.000 description 1
- 206010019070 Hallucination, auditory Diseases 0.000 description 1
- 206010019075 Hallucination, visual Diseases 0.000 description 1
- 208000016619 Histrionic personality disease Diseases 0.000 description 1
- 206010020400 Hostility Diseases 0.000 description 1
- 208000000269 Hyperkinesis Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010021030 Hypomania Diseases 0.000 description 1
- 208000018127 Idiopathic intracranial hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010049977 Intracranial hypotension Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010071082 Juvenile myoclonic epilepsy Diseases 0.000 description 1
- 208000027747 Kennedy disease Diseases 0.000 description 1
- 208000017507 Leigh syndrome Diseases 0.000 description 1
- 201000006792 Lennox-Gastaut syndrome Diseases 0.000 description 1
- 206010027374 Mental impairment Diseases 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 206010027387 Merycism Diseases 0.000 description 1
- 206010067462 Millard-Gubler syndrome Diseases 0.000 description 1
- 206010027951 Mood swings Diseases 0.000 description 1
- 208000019430 Motor disease Diseases 0.000 description 1
- 208000026072 Motor neurone disease Diseases 0.000 description 1
- 208000005314 Multi-Infarct Dementia Diseases 0.000 description 1
- 208000015903 Munchausen Syndrome Diseases 0.000 description 1
- 206010028403 Mutism Diseases 0.000 description 1
- 208000003926 Myelitis Diseases 0.000 description 1
- 208000037004 Myoclonic-astatic epilepsy Diseases 0.000 description 1
- 208000002033 Myoclonus Diseases 0.000 description 1
- 206010028665 Myxoedema Diseases 0.000 description 1
- 208000027120 Narcissistic personality disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010060860 Neurological symptom Diseases 0.000 description 1
- 206010029323 Neuromyopathy Diseases 0.000 description 1
- 208000007125 Neurotoxicity Syndromes Diseases 0.000 description 1
- 206010057852 Nicotine dependence Diseases 0.000 description 1
- 206010029412 Nightmare Diseases 0.000 description 1
- PHVGLTMQBUFIQQ-UHFFFAOYSA-N Nortryptiline Chemical compound C1CC2=CC=CC=C2C(=CCCNC)C2=CC=CC=C21 PHVGLTMQBUFIQQ-UHFFFAOYSA-N 0.000 description 1
- 206010069350 Osmotic demyelination syndrome Diseases 0.000 description 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 description 1
- 208000037158 Partial Epilepsies Diseases 0.000 description 1
- 208000022779 Passive-Aggressive Personality disease Diseases 0.000 description 1
- 206010034158 Pathological gambling Diseases 0.000 description 1
- 206010034759 Petit mal epilepsy Diseases 0.000 description 1
- 206010035039 Piloerection Diseases 0.000 description 1
- 208000010067 Pituitary ACTH Hypersecretion Diseases 0.000 description 1
- 208000020627 Pituitary-dependent Cushing syndrome Diseases 0.000 description 1
- 208000008348 Post-Concussion Syndrome Diseases 0.000 description 1
- 206010036313 Post-traumatic headache Diseases 0.000 description 1
- 208000036757 Postencephalitic parkinsonism Diseases 0.000 description 1
- 206010052469 Postictal paralysis Diseases 0.000 description 1
- 206010036437 Posturing Diseases 0.000 description 1
- 201000010769 Prader-Willi syndrome Diseases 0.000 description 1
- 206010036649 Pressure of speech Diseases 0.000 description 1
- 208000033526 Proximal spinal muscular atrophy type 3 Diseases 0.000 description 1
- 206010037180 Psychiatric symptoms Diseases 0.000 description 1
- 208000036992 Psychogenic pain disease Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037211 Psychomotor hyperactivity Diseases 0.000 description 1
- 206010037213 Psychomotor retardation Diseases 0.000 description 1
- 208000012545 Psychophysiologic disease Diseases 0.000 description 1
- 208000028665 Reactive Attachment disease Diseases 0.000 description 1
- 208000022372 Reading disease Diseases 0.000 description 1
- 208000005793 Restless legs syndrome Diseases 0.000 description 1
- 201000007981 Reye syndrome Diseases 0.000 description 1
- 208000030988 Schizoid Personality disease Diseases 0.000 description 1
- 208000036755 Schizophrenia simple Diseases 0.000 description 1
- 208000036754 Schizophrenia, catatonic type Diseases 0.000 description 1
- 208000036753 Schizophrenia, disorganised type Diseases 0.000 description 1
- 208000036752 Schizophrenia, paranoid type Diseases 0.000 description 1
- 208000036750 Schizophrenia, residual type Diseases 0.000 description 1
- 208000020186 Schizophreniform disease Diseases 0.000 description 1
- 208000008039 Secondary Parkinson Disease Diseases 0.000 description 1
- 206010039917 Selective mutism Diseases 0.000 description 1
- 206010040030 Sensory loss Diseases 0.000 description 1
- 208000000810 Separation Anxiety Diseases 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 208000019568 Shared Paranoid disease Diseases 0.000 description 1
- 208000028810 Shared psychotic disease Diseases 0.000 description 1
- 206010040703 Simple partial seizures Diseases 0.000 description 1
- 208000006981 Skin Abnormalities Diseases 0.000 description 1
- 206010041010 Sleep terror Diseases 0.000 description 1
- 206010041243 Social avoidant behaviour Diseases 0.000 description 1
- 208000032930 Spastic paraplegia Diseases 0.000 description 1
- 206010041549 Spinal cord compression Diseases 0.000 description 1
- 208000028994 Spinal vascular disease Diseases 0.000 description 1
- 206010052945 Status migrainosus Diseases 0.000 description 1
- 206010042008 Stereotypy Diseases 0.000 description 1
- 206010072148 Stiff-Person syndrome Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000005716 Subacute Combined Degeneration Diseases 0.000 description 1
- 206010042635 Suspiciousness Diseases 0.000 description 1
- 206010042953 Systemic sclerosis Diseases 0.000 description 1
- 102100040347 TAR DNA-binding protein 43 Human genes 0.000 description 1
- 101710150875 TAR DNA-binding protein 43 Proteins 0.000 description 1
- 208000008548 Tension-Type Headache Diseases 0.000 description 1
- 206010043495 Thought blocking Diseases 0.000 description 1
- 206010052214 Thought broadcasting Diseases 0.000 description 1
- 206010043496 Thought insertion Diseases 0.000 description 1
- 208000023655 Tic Diseases 0.000 description 1
- 208000025569 Tobacco Use disease Diseases 0.000 description 1
- 206010043994 Tonic convulsion Diseases 0.000 description 1
- 206010044074 Torticollis Diseases 0.000 description 1
- 208000000323 Tourette Syndrome Diseases 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 231100000076 Toxic encephalopathy Toxicity 0.000 description 1
- 206010044334 Trance Diseases 0.000 description 1
- 208000005386 Transient Global Amnesia Diseases 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 229940123445 Tricyclic antidepressant Drugs 0.000 description 1
- 208000001407 Vascular Headaches Diseases 0.000 description 1
- 201000006559 Vertebrobasilar insufficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000035562 Wallenberg syndrome Diseases 0.000 description 1
- 208000013058 Weber syndrome Diseases 0.000 description 1
- 208000002579 Wernicke Aphasia Diseases 0.000 description 1
- 201000006791 West syndrome Diseases 0.000 description 1
- 208000013142 Writer cramp Diseases 0.000 description 1
- 208000006269 X-Linked Bulbo-Spinal Atrophy Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000011152 acquired idiopathic torsion dystonia Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100001133 acute intoxication condition Toxicity 0.000 description 1
- 208000026345 acute stress disease Diseases 0.000 description 1
- 208000018254 acute transverse myelitis Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 102000003802 alpha-Synuclein Human genes 0.000 description 1
- 108090000185 alpha-Synuclein Proteins 0.000 description 1
- 208000007957 amaurosis fugax Diseases 0.000 description 1
- 229960000836 amitriptyline Drugs 0.000 description 1
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 201000002426 animal phobia Diseases 0.000 description 1
- 230000009517 anoxic brain damage Effects 0.000 description 1
- 201000007301 anterior cerebral artery infarction Diseases 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003420 antiserotonin agent Substances 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000030137 articulation disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 201000007742 ataxic cerebral palsy Diseases 0.000 description 1
- 208000018028 athetoid cerebral palsy Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 201000007197 atypical autism Diseases 0.000 description 1
- 208000025748 atypical depressive disease Diseases 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 201000004562 autosomal dominant cerebellar ataxia Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 210000004227 basal ganglia Anatomy 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 208000022257 bipolar II disease Diseases 0.000 description 1
- 206010005159 blepharospasm Diseases 0.000 description 1
- 230000000744 blepharospasm Effects 0.000 description 1
- 208000030963 borderline personality disease Diseases 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 230000005978 brain dysfunction Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 206010007776 catatonia Diseases 0.000 description 1
- 206010007821 cauda equina syndrome Diseases 0.000 description 1
- 210000001159 caudate nucleus Anatomy 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 208000009885 central pontine myelinolysis Diseases 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 208000024825 childhood disintegrative disease Diseases 0.000 description 1
- 208000012601 choreatic disease Diseases 0.000 description 1
- 208000022371 chronic pain syndrome Diseases 0.000 description 1
- 208000021703 chronic tic disease Diseases 0.000 description 1
- 230000027288 circadian rhythm Effects 0.000 description 1
- 229960001653 citalopram Drugs 0.000 description 1
- 229960004606 clomipramine Drugs 0.000 description 1
- 230000002566 clonic effect Effects 0.000 description 1
- 208000028502 clonic seizure Diseases 0.000 description 1
- 208000018912 cluster headache syndrome Diseases 0.000 description 1
- 201000006145 cocaine dependence Diseases 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000007278 cognition impairment Effects 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 208000004209 confusion Diseases 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 210000000877 corpus callosum Anatomy 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 208000026725 cyclothymic disease Diseases 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 231100000868 delusion Toxicity 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 208000030964 dependent personality disease Diseases 0.000 description 1
- 229960003914 desipramine Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000020785 dietary preference Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 201000001110 diplegia of upper limb Diseases 0.000 description 1
- 208000035548 disruptive behavior disease Diseases 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 206010013461 dissociative amnesia Diseases 0.000 description 1
- 229960005426 doxepin Drugs 0.000 description 1
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000004590 drinking behavior Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 229960002866 duloxetine Drugs 0.000 description 1
- 201000007740 dyskinetic cerebral palsy Diseases 0.000 description 1
- 230000008482 dysregulation Effects 0.000 description 1
- 230000010483 emotional dysregulation Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000008965 epilepsia partialis continua Diseases 0.000 description 1
- 201000002933 epilepsy with generalized tonic-clonic seizures Diseases 0.000 description 1
- 208000028329 epileptic seizure Diseases 0.000 description 1
- 229960005086 escitalopram oxalate Drugs 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 230000004424 eye movement Effects 0.000 description 1
- 208000011149 familial idiopathic torsion dystonia Diseases 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 229960002464 fluoxetine Drugs 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229960004038 fluvoxamine Drugs 0.000 description 1
- CJOFXWAVKWHTFT-XSFVSMFZSA-N fluvoxamine Chemical compound COCCCC\C(=N/OCCN)C1=CC=C(C(F)(F)F)C=C1 CJOFXWAVKWHTFT-XSFVSMFZSA-N 0.000 description 1
- 201000002865 focal hand dystonia Diseases 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 238000002599 functional magnetic resonance imaging Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004884 grey matter Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000003400 hallucinatory effect Effects 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000008675 hereditary spastic paraplegia Diseases 0.000 description 1
- 208000003906 hydrocephalus Diseases 0.000 description 1
- 230000001660 hyperkinetic effect Effects 0.000 description 1
- 206010020765 hypersomnia Diseases 0.000 description 1
- 230000001505 hypomanic effect Effects 0.000 description 1
- 238000013095 identification testing Methods 0.000 description 1
- 229960004801 imipramine Drugs 0.000 description 1
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005032 impulse control Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 201000004815 juvenile spinal muscular atrophy Diseases 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 208000011977 language disease Diseases 0.000 description 1
- 238000001285 laser absorption spectroscopy Methods 0.000 description 1
- 208000004343 lateral medullary syndrome Diseases 0.000 description 1
- 201000003723 learning disability Diseases 0.000 description 1
- 230000002197 limbic effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000009593 lumbar puncture Methods 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 210000002418 meninge Anatomy 0.000 description 1
- 230000036630 mental development Effects 0.000 description 1
- 230000003924 mental process Effects 0.000 description 1
- 201000007309 middle cerebral artery infarction Diseases 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 208000027061 mild cognitive impairment Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229960001785 mirtazapine Drugs 0.000 description 1
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 description 1
- 230000004065 mitochondrial dysfunction Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000037230 mobility Effects 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 208000027881 multiple personality disease Diseases 0.000 description 1
- 210000002346 musculoskeletal system Anatomy 0.000 description 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 1
- 230000002151 myoclonic effect Effects 0.000 description 1
- 208000016313 myoclonic-astastic epilepsy Diseases 0.000 description 1
- 208000003786 myxedema Diseases 0.000 description 1
- 230000036562 nail growth Effects 0.000 description 1
- 201000003631 narcolepsy Diseases 0.000 description 1
- 238000003333 near-infrared imaging Methods 0.000 description 1
- 229960001800 nefazodone Drugs 0.000 description 1
- VRBKIVRKKCLPHA-UHFFFAOYSA-N nefazodone Chemical compound O=C1N(CCOC=2C=CC=CC=2)C(CC)=NN1CCCN(CC1)CCN1C1=CC=CC(Cl)=C1 VRBKIVRKKCLPHA-UHFFFAOYSA-N 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 230000008035 nerve activity Effects 0.000 description 1
- 239000003176 neuroleptic agent Substances 0.000 description 1
- 230000000701 neuroleptic effect Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 230000004297 night vision Effects 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 229960001158 nortriptyline Drugs 0.000 description 1
- 206010063546 nosophobia Diseases 0.000 description 1
- 239000011824 nuclear material Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 208000024196 oppositional defiant disease Diseases 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 208000002593 pantothenate kinase-associated neurodegeneration Diseases 0.000 description 1
- 208000024817 paranoid personality disease Diseases 0.000 description 1
- 229960002296 paroxetine Drugs 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 238000012831 peritoneal equilibrium test Methods 0.000 description 1
- 208000024335 physical disease Diseases 0.000 description 1
- 229920000155 polyglutamine Polymers 0.000 description 1
- 108010040003 polyglutamine Proteins 0.000 description 1
- 238000012636 positron electron tomography Methods 0.000 description 1
- 238000012877 positron emission topography Methods 0.000 description 1
- 208000000170 postencephalitic Parkinson disease Diseases 0.000 description 1
- 201000005894 posterior cerebral artery infarction Diseases 0.000 description 1
- 208000021011 postpartum psychosis Diseases 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 208000032207 progressive 1 supranuclear palsy Diseases 0.000 description 1
- 208000036469 progressive bulbar palsy of childhood Diseases 0.000 description 1
- 201000008752 progressive muscular atrophy Diseases 0.000 description 1
- 229960002601 protriptyline Drugs 0.000 description 1
- BWPIARFWQZKAIA-UHFFFAOYSA-N protriptyline Chemical compound C1=CC2=CC=CC=C2C(CCCNC)C2=CC=CC=C21 BWPIARFWQZKAIA-UHFFFAOYSA-N 0.000 description 1
- 208000001381 pseudotumor cerebri Diseases 0.000 description 1
- 230000001107 psychogenic effect Effects 0.000 description 1
- 230000010490 psychological well-being Effects 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 208000026759 receptive aphasia Diseases 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000036387 respiratory rate Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000017779 riboflavin transporter deficiency Diseases 0.000 description 1
- 208000015212 rumination disease Diseases 0.000 description 1
- 230000000698 schizophrenic effect Effects 0.000 description 1
- 201000007982 senile degeneration of brain Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000021317 sensory perception Effects 0.000 description 1
- 208000025874 separation anxiety disease Diseases 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 239000003772 serotonin uptake inhibitor Substances 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 208000016994 somatization disease Diseases 0.000 description 1
- 230000001148 spastic effect Effects 0.000 description 1
- 208000012217 specific developmental disease Diseases 0.000 description 1
- 201000001716 specific phobia Diseases 0.000 description 1
- 208000027765 speech disease Diseases 0.000 description 1
- 230000024188 startle response Effects 0.000 description 1
- 208000005809 status epilepticus Diseases 0.000 description 1
- 208000003755 striatonigral degeneration Diseases 0.000 description 1
- 208000023516 stroke disease Diseases 0.000 description 1
- 230000002739 subcortical effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 102000013498 tau Proteins Human genes 0.000 description 1
- 108010026424 tau Proteins Proteins 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 208000028500 tonic seizure Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 208000027100 transient tic disease Diseases 0.000 description 1
- 208000009174 transverse myelitis Diseases 0.000 description 1
- 230000009529 traumatic brain injury Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- PHLBKPHSAVXXEF-UHFFFAOYSA-N trazodone Chemical compound ClC1=CC=CC(N2CCN(CCCN3C(N4C=CC=CC4=N3)=O)CC2)=C1 PHLBKPHSAVXXEF-UHFFFAOYSA-N 0.000 description 1
- 208000002271 trichotillomania Diseases 0.000 description 1
- 239000003029 tricyclic antidepressant agent Substances 0.000 description 1
- 208000032471 type 1 spinal muscular atrophy Diseases 0.000 description 1
- 208000032527 type III spinal muscular atrophy Diseases 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 201000008767 vascular myelopathy Diseases 0.000 description 1
- 229960004688 venlafaxine Drugs 0.000 description 1
- PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
- A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/70—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6887—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
- A61B5/6888—Cabins
Definitions
- This disclosure is generally related to systems and methods for assessing health. More specifically, this disclosure is related to systems and methods for assessing or determining a mental state of a subject using a kiosk.
- One aspect of assessing or determining a mental state of a subject is that health care professionals have a limited time with each subject to collect information and provide medical services and/or guidance. In collecting information, behavioral health and social history are often missed. These are often missed because they are more time-consuming to collect and the answers are often more sensitive. Moreover, research has shown that subjects are more likely to disclose sensitive information to a computer rather than to staff. Subjects also often spend a considerable amount of time in a waiting room to see a health care professional. Having subjects provide behavioral health and social history information while they are waiting would increase the efficiency of health care delivery.
- the present application fulfills a need for a system and method for collecting information from a subject for mental health evaluation of the information by healthcare professionals to determine the mental competency of the subject and/or the need for treatment of a subject for a behavioral disorder.
- One aspect of the present application relates to a method for assessment of a mental state of a human subject.
- the method includes the steps of: prompting the subject with at least one question on a display of a system for assessment of the mental state of the subject; recording at least one response to the at least one question in the system; calculating an assessment score based on the at least one response; determining by at least one health professional, based on the at least one response and/or the assessment score, the mental state of the subject; and incorporating the mental state of the subject into an electronic health record associated with the subject, wherein the at least one response comprises a long-form answer and wherein the system comprises the display, an input device, a processer, a database and a matrix for converting the at least one response to an assessment score.
- Another aspect of the present application relates to a method for treating a behavioral disorder in a subject in need thereof.
- the method comprises the steps of: prompting the subject with at least one question on a display of a system for assessment of a behavioral disorder of the subject, wherein the system comprises the display, an input device, a processer and a database; recording at least one response to the system, wherein the at least one response comprises a long-form answer; analyzing the at least one response by at least one health professional; determining by the at least one health professional, based on the at least one response, the mental state or behavioral disorder of the subject; and incorporating the mental state or behavioral disorder of the subject into an electronic health record associated with the subject.
- the method further comprises administering to the subject at least one treatment effective for the behavioral disorder.
- the present application provides a means for alerting authorities concerning potential dangers or risks associated with owning and/or operating firearms, motor vehicles, etc.
- the method further comprises the step of retrieving a medical history of the subject from a database and accepting the at least one attribute from the medical history for the determination of the mental state or behavioral disorder of the subject. In some embodiments, the method further comprises the step of presenting one or more questions about the medical history of the subject and receiving responses to the one or more questions about the medical history of the subject for the determination of the mental state or behavioral disorder of the subject.
- the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history triggers an automatic alert for review by the at least one health professional if the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history matches an alert event in an alert database.
- Still another aspect of the present application relates to a system for assessing the mental state of a subject.
- the system comprises: a computer-readable memory, the computer-readable memory configured to store computer-executable instructions; an input device configured to receive an input from the subject; and a processor configured to execute the computer-executable instructions, the computer-executable instructions comprising: prompting the subject with at least one question in a system for assessment of mental state on a display; recording at least one response to the at least one assessment, wherein the at least one response comprises a long-form answer; converting the at least one response into at least one assessment score; generating an output comprising the at least one assessment score for assessment of the mental state of the subject by at least one health professional, generating a report of the mental state of the subject based on the assessment by the at least one health professional and incorporating the report into an electronic health record associated with the subject.
- the processor is configured to execute additional computer-executable instructions, including the step of retrieving a medical history of the subject from a database and accepting the at least one attribute from the medical history for the determination of the mental state of the subject. In some embodiments, the processor is configured to execute additional computer-executable instructions, including the step of presenting one or more questions about the medical history of the subject and receiving responses to the one or more questions about the medical history of the subject for the determination of the mental state of the subject.
- the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history triggers the system to present an automatic alert for review by the at least one health professional if the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history matches an alert event in an alert database.
- the system further comprises a database of alert events, wherein a response to the at least one question, and/or an attribute of a medical history of the subject, triggers the system to present an automatic alert for review by the at least one health professional if the response and/or the attribute matches an alert event in the database.
- FIG. 1 is a block diagram illustrating exemplary hardware components that may be used for implementing aspects of the system.
- FIGS. 2A and 2B show an exemplary method of using the wellness assessment behavioral health kiosk.
- FIG. 3 shows another exemplary method of using the wellness assessment behavioral health kiosk.
- the term “mental health” relates to the psychological well-being of a subject.
- mental health includes “subjective well-being, perceived self-efficacy, autonomy, competence, inter-generational dependence, and self-actualization of one's intellectual and emotional potential, among others” (World Health Organization, “World Health Report 2001: Mental Health: New Understanding, New Hope,” 2001).
- the WHO further states that the well-being of an individual is encompassed in the realization of their abilities, coping with normal stresses of life, productive work and contribution to their community.
- mental illness As used herein, the terms “mental illness,” “mental disorder”, “behavioral disorder” and “psychiatric disorder” relate to mental health conditions comprising a disorder in the mood, thinking or behavior of a subject.
- Mental illnesses or behavioral disorders commonly present with cognitive deficits and mood dysregulation.
- Mental illnesses or behavioral disorders are generally defined by a combination of how a person feels, acts, thinks or perceives.
- Common examples of mental illnesses or behavioral disorders include schizophrenia, Alzheimer's disease, Huntington's disease, Cushing's disease, Lewy body disease, multiple sclerosis, stroke, addictive disorder, pervasive development disorder, autism, fragile X syndrome, anxiety disorder, mood disorders, Prader-Willi syndrome, bipolar disorder, depressive disorders, behavioral disorders, eating disorders, vascular dementia, mild cognitive impairment, autism, dementia and delirium.
- the mental illnesses or behavioral disorders also include an organic mental disorder, a mental or behavioral disorder caused by psychoactive substance use, a schizophrenia, schizotypal, or delusional disorder, a mood (affective) disorder, neurotic, stress-related, or somatoform disorder, a behavioral syndrome, an adult personality or behavior disorder, a psychological development disorder, or a child onset behavioral or emotional disorders.
- Depressive disorders affect over fifteen percent (15%) of the population. Depression is a mental state of depressed mood characterized by feelings of sadness, despair, and discouragement. Depression includes the normal feelings of “the blues” through dysthymic disorder to major depressive disorder. Dysthymic disorder is a mood disorder characterized by depressed feeling (sad, blue, low), loss of interest or pleasure in usual activities, and at least some of the following: changes in appetite and sleep patterns, lack of energy, low self-esteem, poor concentration or decision-making skills, and feelings of hopelessness. In dysthymic disorders, symptoms have persisted for more than two years but are not severe enough to meet the criteria for major depressive disorder.
- Major depressive disorder is characterized by major depressive episodes, a period of daily depressed mood or loss of interest or pleasure in almost all activities with some combination of the following symptoms: altered appetite, weight, or sleep patterns, psychomotor agitation or retardation, diminished capacity for thinking, concentration, or decisiveness, lack of energy and fatigue, feelings of worthlessness, self-reproach, or guilt, frequent thoughts of death or suicide, plans or attempts to commit the latter (Diagnostic and Statistical Manual of Mental Disorders, 4th ed., American Psychiatric Association, Washington D.C., 1994).
- the term “behavioral disorder” relates to a disorder characterized by displayed behaviors over a long period of time which significantly deviate from socially acceptable norms for a person's age and situation.
- exemplary behavioral disorders include, but are not limited to, anxiety disorders (including post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), generalized anxiety disorder, and panic disorder), disruptive disorders, dissociative disorders, emotional disorders, pervasive developmental disorders and substance abuse.
- the behavior disorder includes, or is caused by, a mental disorder or a behavioral disorder.
- the term “mental competency” relates to the ability of a subject to act in the circumstances, including the ability to perform a task, job or occupation, or to reason or make decisions.
- a subject's mental competency can be assessed by the present method and system to determine, for example, whether the subject should be allowed to purchase a firearm, or whether the subject can perform a job function, such as a pilot.
- a system of the present application can be made available at point of service locations including, but not limited to, retail establishments, medical facilities or offices, or employment agencies/offices.
- the term “assessment” relates to determination of the mental state of a subject, determination of changes in the mental state of a subject, determination/diagnosis of a mental illness in a subject or determination/diagnosis of changes in a mental illness in a subject.
- long-form answer relates to an answer to a question that is more than a single word answer such as, yes, no, maybe, true or false.
- the term “subject” relates to a human individual or subject in need of analysis of a mental state for mental competency or diagnostic purposes.
- Health professional or “healthcare provider” relate to an individual who provides preventive, curative, promotional or rehabilitative health care services in a systematic way to people, families or communities.
- Health professionals include, but are not limited to, physicians, psychiatrists, psychologists, pharmacists, physician assistants, nurses, nurse practitioners, advanced practice registered nurses, surgeons, surgeon's assistant, therapists, chiropractors, clinical officers, social workers, operating department practitioners, and a wide variety of other human resources trained to provide some type of health care service.
- the terms “physician” or “medical doctor” relate to a professional who practices medicine, and is concerned with promoting, maintaining, or restoring health through the study, diagnosis, and treatment of disease, injury, and other physical and mental impairments.
- a physician may include, but is not limited to, a primary care physician of a subject; a staff physician in a hospital, nursing home, clinic or other medical care facility; a physician who is a member of a medical group; a general practitioner; a Doctor of Osteopathic Medicine or a family physician.
- the term “physician” does not include a psychiatrist or a psychologist.
- mental health professional relates to a health care practitioner or community services provider who offers services for the purpose of improving an individual's mental health or to treat mental illness.
- a mental health professional includes, but is not limited to, a psychiatrist and a psychologist.
- One aspect of the present application relates to a method for assessment of a mental state of a human subject.
- the method comprises the steps of: prompting the subject with at least one question on a display of a system for assessment of the mental state of the subject; recording at least one response to the at least one question in the system; calculating an assessment score based on the at least one response; determining by at least one health professional, based on the at least one response and/or the assessment score, the mental state of the subject; and incorporating the mental state of the subject into an electronic health record associated with the subject, wherein the at least one response comprises a long-form answer and wherein the system comprises the display, an input device, a processer, a database and a matrix for converting the at least one response to an assessment score.
- the method further comprises the step of retrieving a medical history of the subject from a database and accepting the at least one attribute from the medical history for the determination of the mental state of the subject. In some embodiments, the method further comprises the step of presenting one or more questions about the medical history of the subject and receiving responses to the one or more questions about the medical history of the subject for the determination of the mental state of the subject.
- the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history triggers an automatic alert for review by the at least one health professional if the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history matches an alert event in an alert database.
- the method comprises analyzing the at least one response by two health professionals.
- the at least one health professional is a mental health professional.
- the mental health professional is a psychiatrist.
- the at least one health professional is a physician.
- the two health professionals are a physician and a mental health professional.
- the assessment of a mental state includes the determination or diagnosis of a mental illness or a behavioral disorder.
- the mental illness or a behavioral disorder is caused or related to a disorder of the central nervous system.
- disorder of the central nervous system refers to a disorder affecting either the spinal cord (e.g., a myelopathy) or brain (e.g., an encephalopathy) of a subject, which commonly presents with neurological and/or psychiatric symptoms.
- CNS disorders include many neurodegenerative diseases (e.g., Huntington's disease, Amyotrophic lateral sclerosis (ALS), hereditary spastic hemiplegia, primary lateral sclerosis, spinal muscular atrophy, Kennedy's disease, Alzheimer's disease, ataxias, Huntington's disease, Lewy body disease, a polyglutamine repeat disease, and Parkinson's disease) and behavioral disorders (e.g., mood disorders, schizophrenias, and autism).
- neurodegenerative diseases e.g., Huntington's disease, Amyotrophic lateral sclerosis (ALS), hereditary spastic hemiplegia, primary lateral sclerosis, spinal muscular atrophy, Kennedy's disease, Alzheimer's disease, ataxias, Huntington's disease, Lewy body disease, a polyglutamine repeat disease, and Parkinson's disease
- ataxia include Friedreich's ataxia and the spinocerebellar ataxias.
- CNS disorders do not include disorders resulting from acute viral
- Non-limiting examples of CNS disorders include neurodegenerative disorders of the central nervous system, systemic atrophies primarily affecting the central nervous system, extrapyramidal and movement disorders, demyelinating disorders of the central nervous system, episodic or paroxysmal disorders of the central nervous system, paralytic syndromes of the central nervous system, nerve, nerve root, or plexus disorders of the central nervous system, organic mental disorders, mental or behavioral disorders caused by psychoactive substance use, schizophrenic, schizotypal, or delusional disorders, mood (affective) disorders, neurotic, stress-related, or somatoform disorders, behavioral syndromes, adult personality or behavior disorders, psychological development disorders, and child onset behavioral or emotional disorders.
- DSM-5 The World Health Organization, The International Classification of Diseases, 10th revision (ICD-10), Chapter V.
- the mental illness or behavioral disorder is caused by neurodegenerative CNS disorders.
- Neurodegenerative CNS disorders are typically characterized by progressive dysfunction and/or cell death in the central nervous system.
- the hallmark of many neurodegenerative CNS disorders is the accumulation of misfolded proteins, such as beta-amyloid, tau, alpha-synuclein, and TDP-43, both intracellularly and extracellularly.
- Many neurodegenerative diseases are also associated with gross mitochondrial dysfunction.
- Neurodegenerative CNS disorders include Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease, and Amyotrophic lateral sclerosis (ALS), a circumscribed brain atrophy (e.g., Pick's disease); senile degeneration of brain; a degeneration of nervous system due to alcohol; grey-matter degeneration (e.g., Alpers' disease); Lewy body dementia, subacute necrotizing encephalopathy (e.g., Leigh's disease); and subacute combined degeneration of spinal cord.
- AD Alzheimer's disease
- PD Parkinson's disease
- Huntington's disease Huntington's disease
- ALS Amyotrophic lateral sclerosis
- a circumscribed brain atrophy e.g., Pick's disease
- senile degeneration of brain a degeneration of nervous system due to alcohol
- grey-matter degeneration e.g., Alpers' disease
- Lewy body dementia e.g., Leigh's disease
- the mental illness or behavioral disorder is caused by CNS disorders selected from the group consisting of a systemic atrophy primarily affecting the central nervous system, an extrapyramidal and movement disorder, a neurodegenerative disorder of the central nervous system, a demyelinating disorder of the central nervous system, an episodic or paroxysmal disorder of the central nervous system, a paralytic syndrome of the central nervous system, a nerve, nerve root, or plexus disorder of the central nervous system.
- CNS disorders selected from the group consisting of a systemic atrophy primarily affecting the central nervous system, an extrapyramidal and movement disorder, a neurodegenerative disorder of the central nervous system, a demyelinating disorder of the central nervous system, an episodic or paroxysmal disorder of the central nervous system, a paralytic syndrome of the central nervous system, a nerve, nerve root, or plexus disorder of the central nervous system.
- Non-limiting examples of systemic atrophies that primarily affect the central nervous system include: Huntington's disease; hereditary ataxias (e.g., congenital non-progressive ataxia, early-onset cerebellar ataxias—such as early-onset cerebellar ataxia with essential tremor, Hunt's ataxia, early-onset cerebellar ataxia with retained tendon reflexes, Friedreich's ataxia, and X-linked recessive spinocerebellar ataxia—late-onset cerebellar ataxia, ataxia telangiectasia (Louis-Bar syndrome), or hereditary spastic paraplegia); a spinal muscular atrophy or related disorder thereof (e.g., Werdnig-Hoffman disease (Type 1), progressive bulbar palsy of childhood (Fazio-Londe syndrome), Kugelberg-Welander disease (Type 3), or a motor neuron disease—such as familial motor neuron disease, amyotrophic lateral sclerosis
- the mental illnesses or behavioral disorders are caused by the CNS disorder selected from the group consisting of Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis (ALS), Huntington's disease, cerebral palsy, bipolar disorder, schizophrenia, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS), or Pediatric acute-onset neuropyschiatric syndrome (PANS).
- the CNS disorder selected from the group consisting of Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis (ALS), Huntington's disease, cerebral palsy, bipolar disorder, schizophrenia, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS), or Pediatric acute-onset neuropyschiatric syndrome (PANS).
- the mental illness or behavioral disorder is caused by an extrapyramidal and movement disorder.
- extrapyramidal and movement disorders that affect the central nervous system include: Parkinson's disease; a secondary parkinsonism (e.g., malignant neuroleptic syndrome or postencephalitic parkinsonism); a degenerative disease of the basal ganglia (e.g., Hallervorden-Spatz disease, progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski disease), or striatonigral degeneration), a dystonia (e.g., drug-induced dystonia, idiopathic familial dystonia, idiopathic non-familial dystonia, spasmodic torticollis, idiopathic orofacial dystonia—such as orofacial dyskinesia—or blepharospasm); an essential tremor; a drug-induced tremor, myoclon
- the mental illness is dementia.
- the dementia is a cortical dementia (associated, for example, with Alzheimer's) arising from a disorder affecting the cerebral cortex.
- the dementia is a subcortical dementia (associated, for example, with Parkinson's disease and Huntington's disease) resulting from dysfunction in the parts of the brain that are beneath the cortex.
- the dementia is a side effect of drug administration.
- the dementia is a side effect of the administration of a chemotherapeutic agent.
- the dementia is a result of undergoing cardiac bypass.
- the dementia is a result of a vascular disorder (e.g., myocardial infarction, stroke, high blood pressure).
- the dementia is a result of depression.
- the mental illness or behavioral disorder is caused by a demyelinating disorder of the central nervous system.
- demyelinating disorders that affect the central nervous system include: multiple sclerosis; an acute disseminated demyelination disorder (e.g., neuromyelitis optica (Devic's syndrome) or acute and subacute hemorrhagic leukoencephalitis (Hurst's disease)); diffuse sclerosis; central demyelination of corpus callosum; central pontine myelinolysis; acute transverse myelitis in demyelinating disease of central nervous system; subacute necrotizing myelitis; and concentric sclerosis (Balo disease).
- an acute disseminated demyelination disorder e.g., neuromyelitis optica (Devic's syndrome) or acute and subacute hemorrhagic leukoencephalitis (Hurst's disease)
- diffuse sclerosis e.g., central demyelination of
- the mental illness or behavioral disorder is caused by an episodic or paroxysmal disorder of the central nervous system.
- episodic and paroxysmal disorders that affect the central nervous system include: epilepsy (e.g., localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures; localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures; a benign epileptic syndrome—such as myoclonic epilepsy in infancy and neonatal convulsions (familial)—childhood absence epilepsy (e.g., pyknolepsy), epilepsy with grand mal seizures on awakening, a juvenile epilepsy—such as absence epilepsy or myoclonic epilepsy (impulsive petit mal)—a nonspecific epileptic seizu
- epilepsy e
- the mental illness or behavioral disorder is caused by a CNS disorder is a paralytic syndrome of the central nervous system.
- paralytic syndromes that affect the central nervous system include: a cerebral palsy (e.g., spastic quadriplegic cerebral palsy, spastic diplegic cerebral palsy, spastic hemiplegic cerebral palsy, dyskinetic cerebral palsy, or ataxic cerebral palsy); a hemiplegia (e.g., flaccid hemiplegia or spastic hemiplegia); a paraplegia or tetraplegia (e.g., flaccid paraplegia, spastic paraplegia, paralysis of both lower limbs, lower paraplegia, flaccid tetraplegia, spastic tetraplegia, or quadriplegia); diplegia of upper limbs; monoplegia of a lower limb, monoplegia of an upper limb; cau
- the mental illness or behavioral disorder is caused by an otherwise classified disorder of the central nervous system.
- these disorders include: hydrocephalus; a toxic encephalopathy, a cerebral cyst; anoxic brain damage; benign intracranial hypertension; postviral fatigue syndrome; an encephalopathy; compression of brain; cerebral oedema; Reye's syndrome; postradiation encephalopathy; traumatic brain injury; syringomyelia; syringobulbia; a vascular myelopathy; spinal cord compression; myelopathy; a cerebrospinal fluid leak; a disorder of the meninges (e.g., cerebral or spinal meningeal adhesion); and a post-procedural disorder of nervous system (e.g., cerebrospinal fluid leak from spinal puncture, an adverse reaction to a spinal or lumbar puncture, or intracranial hypotension following ventricular shunting).
- a post-procedural disorder of nervous system e.g., cerebrospinal fluid
- the mental illness is an organic mental disorder.
- organic mental disorders that affect the central nervous system include: dementia (e.g., dementia associated with Alzheimer's disease, Pick's disease, Creutzfeldt-Jakob disease, Huntington's disease, Parkinson's disease, or human immunodeficiency virus (HIV) disease, or vascular dementia—such as multi-infarct dementia); organic amnesic syndrome not induced by alcohol and other psychoactive substances); delirium not induced by alcohol and other psychoactive substances; a mental disorder due to brain damage and dysfunction and to physical disease (e.g., organic hallucinosis, organic catatonic disorder, organic delusional (schizophrenia-like) disorder, organic mood (affective) disorder, organic anxiety disorder, organic dissociative disorder; organic emotionally labile (asthenic) disorder; a mild cognitive disorder, or organic brain syndrome); and a personality and behavioral disorders due to brain disease, damage and dysfunction (e.g., organic personality disorder, postencephalitic syndrome, or post), dementia, or vascular dementia
- the mental illness or behavioral disorder is a mental or behavioral disorder caused by psychoactive substance use.
- mental or behavioral disorders caused by psychoactive substance use that affect the central nervous system include: acute intoxication (e.g., from alcohol, opioid, cannabis , benzodiazepine, or cocaine use); a dependence syndrome (e.g., from alcohol, opioid, cannabis , benzodiazepine, cocaine, or nicotine addiction); a withdrawal syndrome (e.g., an alcohol or benzodiazepine withdrawal syndrome); delirium tremens; and a psychotic disorder (e.g., alcoholic hallucinosis or stimulant psychosis); an amnesic syndrome (e.g., Korsakoff s syndrome); a residual and late-onset psychotic disorder (e.g., posthallucinogen perception disorder).
- acute intoxication e.g., from alcohol, opioid, cannabis , benzodiazepine, or cocaine use
- a dependence syndrome e.g., from alcohol, opioid, cannabis , benzodiazepine
- the mental illness or behavioral disorder is an autism spectrum disorder.
- the CNS disorder is autism, Asperger syndrome, pervasive developmental disorder not otherwise specified (PDD-NOS), childhood disintegrative disorder, or Rett syndrome.
- the mental illness or behavioral disorder is a schizophrenia, schizotypal, or delusional disorder.
- schizophrenia, schizotypal, and delusional disorders that affect the central nervous system include: schizophrenia (e.g., paranoid schizophrenia, hebephrenic schizophrenia (disorganized schizophrenia), catatonic schizophrenia, undifferentiated schizophrenia, post-schizophrenic depression, residual schizophrenia, simple schizophrenia, cenesthopathic schizophrenia, schizophreniform disorder, or schizophreniform psychosis); schizotypal disorder; a persistent delusional disorder (e.g., delusional disorder, delusional dysmorphophobia, involutional paranoid state, or paranoia querulans); an acute or transient psychotic disorder (e.g., acute polymorphic psychotic disorder without symptoms of schizophrenia, acute polymorphic psychotic disorder with symptoms of schizophrenia, or acute schizophrenia-like psychotic disorder); an induced delusional disorder (e.g., folie avers, induced paranoid disorder,
- the mental illness or behavioral disorder is a mood (affective) disorder.
- mood (affective) disorders that affect the central nervous system include: a manic episode (e.g., hypomania, mania without psychotic symptoms, or mania with psychotic symptoms); a bipolar affective disorder (e.g., bipolar affective disorder—current episode hypomanic, bipolar affective disorder—current episode manic without psychotic symptoms, bipolar affective disorder—current episode manic with psychotic symptoms, bipolar affective disorder—current episode mild or moderate depression, bipolar affective disorder—current episode severe depression without psychotic symptoms, bipolar affective disorder—current episode severe depression with psychotic symptoms, bipolar affective disorder—current episode mixed, bipolar affective disorder—currently in remission, bipolar II disorder, or recurrent manic episodes); a depressive episode (e.g., mild depressive episode, moderate depressive episode, severe depressive episode without psychotic symptoms, severe depressive episode with psychotic symptoms, atypical depression, or single episodes of “m
- the mental illness or behavioral disorder is a neurotic, stress-related, or somatoform disorder.
- neurotic, stress-related, or somatoform disorders that affect the central nervous system include: a phobic anxiety disorder (e.g., agoraphobia, anthropophobia, social neurosis, acrophobia, animal phobias, claustrophobia, or simple phobia); an otherwise categorized anxiety disorder (e.g., panic disorder (episodic paroxysmal anxiety) or generalized anxiety disorder); obsessive-compulsive disorder; an adjustment disorder (e.g., acute stress reaction; post-traumatic stress disorder, or adjustment disorder); a dissociative (conversion) disorder (e.g., dissociative amnesia, dissociative fugue, dissociative stupor; trance disorder, possession disorder, dissociative motor disorder, dissociative convulsions, dissociative anaesthesia and sensory loss, mixed dissociative (conversion) disorder, Ganser's syndrome, or
- the mental illness or behavioral disorder is a behavioral syndrome associated with physiological disturbances or physical factors.
- behavioral syndromes associated with physiological disturbances or physical factors that affect the central nervous system include: an eating disorder (e.g., anorexia nervos, atypical anorexia nervosa, bulimia nervosa, atypical bulimia nervosa, overeating associated with other psychological disturbances, vomiting associated with other psychological disturbances, or pica in adults); a nonorganic sleep disorder (e.g., nonorganic insomnia, nonorganic hypersomnia, nonorganic disorder of the sleep-wake schedule, sleepwalking (somnambulism), sleep terrors (night terrors), or nightmares); a sexual dysfunction not caused by organic disorder or disease; a mental or behavioral disorder associated with the puerperium (e.g., postnatal depression, postpartum depression, or puerperal psychosis); and abuse of non-dependence-producing substances.
- an eating disorder e.g., anorexia
- the mental illness or behavioral disorder is an adult personality or behavior disorder.
- adult personality and behavior disorders that affect the central nervous system include: a specific personality disorder (e.g., paranoid personality disorder, schizoid personality disorder, a dissocial personality disorder—such as antisocial personality disorder—an emotionally unstable personality disorder—such as borderline personality disorder—histrionic personality disorder, an anankastic personality disorder—such as obsessive-compulsive personality disorder, anxious (avoidant) personality disorder, dependent personality disorder, eccentric personality disorder, haltlose personality disorder, immature personality disorder, narcissistic personality disorder, passive-aggressive personality disorder, or psychoneurotic personality disorder); mixed personality disorder; a habit or impulse disorder (e.g., pathological gambling, pathological fire-setting (pyromania), pathological stealing (kleptomania), or trichotillomania); and Munchausen syndrome.
- a specific personality disorder e.g., paranoid personality disorder, schizoid personality disorder, a dissocial personality disorder—such as
- the mental illness or behavioral disorder is a psychological development disorder.
- psychological development disorders that affect the central nervous system include: a developmental disorder of speech or language (e.g., specific speech articulation disorder, expressive language disorder, receptive language disorder (receptive aphasia), acquired aphasia with epilepsy (Landau-Kleffner disorder), or lisping); a developmental disorder of scholastic skills (e.g., a specific reading disorder—such as developmental dyslexia—specific spelling disorder, a specific disorder of arithmetical skills—such as developmental acalculia and Gerstmann syndrome—or a mixed disorder of scholastic skills); a developmental disorder of motor function (e.g., developmental dyspraxia); a mixed specific developmental disorder; and a pervasive developmental disorder (e.g., childhood autism, atypical autism, Rett's syndrome, overactive disorder associated with mental retardation and stereotyped movements, or Asperger's syndrome).
- the mental illness or behavioral disorder is a behavioral or emotional disorder with onset usually occurring in childhood and adolescence.
- behavioral or emotional disorders with onset usually occurring in childhood and adolescence that affect the central nervous system include: a hyperkinetic disorder (e.g., a disturbance of activity and attention—such as attention-deficit hyperactivity disorder and attention deficit syndrome with hyperactivity—or hyperkinetic conduct disorder); a conduct disorder (e.g., conduct disorder confined to the family context, unsocialized conduct disorder, socialized conduct disorder, or oppositional defiant disorder); a mixed disorder of conduct or emotions (e.g., depressive conduct disorder); an emotional disorder with onset specific to childhood (e.g., separation anxiety disorder of childhood, phobic anxiety disorder of childhood, social anxiety disorder of childhood, sibling rivalry disorder, identity disorder, or overanxious disorder); a disorder of social functioning with onset specific to childhood and adolescence (e.g., elective mutism, reactive attachment disorder of childhood, or
- the at least one response prompts the system to present at least one additional question related to the at least one response.
- the at least one response prompts the system to present at least one set of additional questions related to the at least one response.
- a set of additional questions comprises at least 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 questions.
- the at least one response or responses of the subject to the at least one additional question or to the at least one set of additional questions prompts the system to present at least one additional question related to a different facet of the mental health of the subject.
- the at least one response or responses of the subject to the at least one additional question or to the at least one set of additional questions prompts the system to present at least one set of additional questions related to a different facet of the mental health of the subject.
- a set of additional questions comprises at least 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 questions.
- the system present the subject with questions or sets of questions related to at least 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 facets of mental health.
- the method comprises analyzing the at least one response by two health professionals.
- the at least one health professional is a mental health professional.
- the mental health professional is a psychiatrist.
- the at least one health professional is a physician, who is in some embodiments the primary care physician of the subject.
- the two health professionals are a physician and a mental health professional.
- the method further comprises the step of retrieving a medical history of the subject from a database and accepting the at least one attribute from the medical history for the determination of the mental state of the subject. In some embodiments, the method further comprises the step of presenting one or more questions about the medical history of the subject and receiving responses to the one or more questions about the medical history of the subject for the determination of the mental state or behavioral disorder of the subject.
- Attributes from the medical history include a list of previous illnesses, symptoms, medicines, treatments, health risk factors, operations, and/or doctor visits for the subject.
- the medical history includes life history and/or social history characteristics such as smoking, drinking, drug use, sexual history, exercise history, eating history, nutraceutical history, or the like.
- the medical history includes a family medical history.
- a family medical history may include a list of previous illnesses, symptoms, medicines, treatments, health risk factors, operations, and/or doctor visits associated with family members related to the subject.
- the at least one attribute includes mental attributes of the subject.
- a mental attribute may include an attribute that may be related to and/or associated with basic mental function and/or high-level brain function.
- Some examples of a mental attribute may include an indication of learning disability, cognitive disability, measurements of brain activity, for example using functional MRI or near infra-red technology, and/or measurements of mental development.
- the at least one attribute includes descriptions of mental symptoms of the subject.
- a mental symptom may include a manifestation, sign, and/or an indication of the presence of a disease and/or some other mental disorder and/or abnormality.
- Some examples of a mental symptom may include lack of attention, indication of stress, hyperactivity, nervousness, and/or lack of responsiveness.
- the at least one attribute includes indication of anxiety, an appearance, a behavior, depression, fear, inattention, a mood disturbance, a phobia, or a psychological test result.
- Anxiety may include feelings of fear, apprehension, and/or worry and may be accompanied by physical sensations.
- An appearance may include an outward, audible, and/or visible aspect of a person and/or thing associated with a person.
- a behavior may include the manner in which a person and/or thing associated with a person acts and/or reacts.
- Depression may include a mental state characterized by pessimism, a sense of inadequacy, despondence, despair, a low level of energy, and/or a lack of activity.
- Fear may be caused by impending danger, perceived evil, and/or pain, whether real or imagined.
- Inattention may include the failure of a person to focus attention.
- a mood disturbance may include a change in emotional state.
- a phobia may include an irrational, and/or persistent fear of certain situations, objects, activities, and/or people.
- a psychological test result may include a sample behavior for inferring a certain generalization about a person. For example, a personality test result may indicate that person has obsessive/compulsive characteristics.
- mental indication accepter module 636 may include a computer processor.
- the at least one attribute includes at least one measurement associated with at least one of brain activity, cardiac activity, vascular activity, peripheral neural signals, hemodynamic activity, or metabolic activity.
- Brain activity may include the electrical activity of the brain, such as that measured by EEG, MEG, or the like. Other brain activity measurements may include functional MM imaging, near infra-red imaging, PET scanning, or the like.
- Cardiac activity may include electrical activity in the heart, such as that measured by EKG or visual imaging.
- Vascular activity may include any activity and/or function of the circulatory system.
- Peripheral neural signals may include neural signals sent through the peripheral nervous system.
- Hemodynamic activity may include any activity associated with the circulatory system.
- Metabolic activity may include any activity associated with the biochemical reactions occurring in a living organism.
- mental activity accepter module 638 may include a computer processor.
- the at least one attribute includes measurement of at least one brain activity surrogate marker.
- Brain activity surrogate markers may include indicators of attention, approval, disapproval, recognition, cognition, memory, trust, or the like in response to a stimulus, other than measurement of brain activity associated with the stimulus.
- Some examples of surrogate markers may include a skin response to a stimulus; a face pattern indicative of approval, disapproval, or emotional state; eye movements or pupil movements indicating visual attention to an object; voice stress patterns indicative of a mental state, or the like.
- Surrogate markers may be used in conjunction with brain activity measurements for higher confidence in a predictive or interpretational outcome.
- brain activation of the caudate nucleus in combination with calm voice patterns may increase confidence in a predictor of trust between a subject and a stimulus. Additional discussion regarding surrogate markers may be found in Cohn, J. N., Introduction to Surrogate Markers, CIRCULATION 109: IV20-21, American Heart Association, (2004), which is incorporated herein by reference.
- the at least one attribute includes measurement of iris dilation or constriction, gaze tracking, skin response, or voice response.
- the medical history includes measurement of changes in the movement of an individual's iris (with corresponding changes in the size of the pupil) before, during, and/or after administration of a bioactive agent and/or an artificial sensory experience. Such measurements of physiologic activity that indicate brain activity and/or mental state may be carried out at a time that is proximate to administration of a bioactive agent and/or an artificial sensory experience.
- the at least one attribute includes measurement of skin response of the subject.
- Brain activity may be determined by detection of a skin response associated with a stimulus.
- One skin response that may correlate with mental state and/or brain activity is galvanic skin response (GSR), also known as electrodermal response (EDR), psychogalvanic reflex (PGR), or skin conductance response (SCR).
- GSR galvanic skin response
- EDR electrodermal response
- PGR psychogalvanic reflex
- SCR skin conductance response
- GSR is typically measured using electrodes to measure skin electrical signals.
- an Ultimate Game study measured skin-conductance responses as a surrogate marker or autonomic index for affective state, and found higher skin conductance activity for unfair offers, and as with insular activation in the brain, this measure discriminated between acceptances and rejections of these offers. See Sanfey, “Social Decision-Making: Insights from Game Theory and Neuroscience,” Science, vol. 318, pp. 598-601 (26 Oct. 2007), which is incorporated herein by reference.
- Other skin responses may include flushing, blushing, goose bumps, sweating, or the like.
- the at least one attribute includes measurement of voice response.
- Voice response may include speech captured by a microphone during presentation of a characteristic. Speech or voice can be measured, for example, by examining voice, song, and/or other vocal utterances of a subject before, during, and/or after administration of a bioactive agent and/or an artificial sensory experience to an individual. Such measurements may include, for example, as discussed above, layered voice analysis, voice stress analysis, or the like.
- the at least one attribute includes personal identification data, physical characteristics data, health profile data, family health history data, drug and vitamin/mineral supplement data, health baseline data, diet and nutritional data, environmental exposure data, and behavioral data.
- the personal identification data comprises essential personal information that facilitates the identification of an individual and the establishment of core demographic characteristics.
- the personal identification data includes name, address, residence history, age, gender, race, ethnicity, education, sexual preference, martial status, living arrangements, marital history, children, occupation, work history, home and work environments, travel history, military service history, genealogy, relationships, recreational activities and the like.
- Sensitive information such as name and street address, may be segregated and coded for privacy and security.
- the physical characteristics data includes height, weight, body fat ratio, body symmetry and dimensions, skin shade and texture, eye color, hair growth/color and texture, strength symmetry, endurance, coordination, posture, gait, nail growth and features, feet size, physical peculiarities, physical deformities, growths, blemishes, teeth and gums, flexibility, and the like. These characteristics are useful in establishing the subscriber's physical uniqueness as well as their membership in population groups that share certain characteristics.
- the health profile data comprises a broad array of information pertaining to the subscriber's psychological and physiological characteristics and condition, medical history data, hazardous and toxic material exposure data, allergies data, disabilities, reproductive history, depression data, family (genealogy) health history data stress level data, mental condition data, current health conditions data, physical sensitivities and pain data, activity level and physical fitness data, illnesses history data, history of injuries data, chronic conditions data, visual acuity data, night vision data, hearing acuity data, reaction time data and the like.
- the health profile data also incorporates the results of quantitative tests including blood chemistry tests, breath analysis (i.e., laser absorption spectroscopy), medical imaging (i.e., x-rays, magnetic resonance imaging, lithotripsy, computed tomography, fluorescence spectroscopy, ultrasounds, thermographs, and others), photographic imaging, and other psychological, physical, and physiological tests.
- the family health history addresses the health conditions and unique characteristics of the subject's living and deceased blood relatives.
- the family health history data is comprised of personal description data, physical description data, physical characteristics, demographic data, occupational data, disabilities, behaviors, health and medical histories, and the like.
- the family history data collection includes names, birthdates, place of birth, number of children (including genders and birthdates), places of residency, health histories, ages at death, height, weight, physical and health peculiarities, chronic conditions, sensitivities/allergies, disease history, cause of death, health conditions at time of death, history of injuries, deformities, visual acuity, hearing acuity, mental condition and acuity, disabilities, occupations/pro professions, medication history (including diagnosis, treatments, test results, evaluations, and the like), reproductive histories, alcohol and drug usage, blood types, and other psychological, physical, physiological and behavioral details that would be useful in the identification of genetic characteristics and predispositions.
- the drug and vitamin/mineral supplement data comprises a detailed history of prescription and non-prescription drugs, vitamin supplements, herbs, and mineral supplement usages. Included in the history may be the item description, dosage, frequency taken, date started, reason for taking, date stopped, reason for stopping, and observed effects, side effects, reactions, and the like.
- the health baseline data may, in part, be derived from information compiled in previous databases including, the personal identification data, physical characteristics data and health profile data.
- Certain key psychological characteristics i.e., depression, confusion, neurosis and other like mental conditions or mental cognitive peculiarities
- physical characteristics i.e., height, weight, body fat ratio, posture, flexibility, mobility, hair growth, hair color, skin color/tone, eye color and the like
- physiological characteristics i.e., visual performance, hearing performance, blood pressure, heart rate, repertory rate, heart rhythm, blood chemistry, and other major organ system performance characteristics
- medical conditions may be recorded and updated over a period of time.
- the resulting database will depict each characteristic separately and their respective performance values.
- the data may be subject to a patterns-analysis, which identifies repetitive fluctuations in order to establish predictable patterns, ranges of fluctuation and rate of change. Where possible, certain pattern fluctuations are linked to predictable cycles, such as, time-of-day, seasons, and biological cycles.
- the subscriber's physical, psychological, physiological and behavioral characteristics may be assessed relative to authoritative standards and norms of similar population groups.
- the resulting compilation of data forms a baseline or reference-point to which new data, representing the latest health condition of the subscriber for comparison.
- the comparison provides a basis for determining whether the new data is consistent with or deviates from the baseline. The deviations may be positive (improvements in a condition), negative (evidence of deterioration), or they may be evidence of a new condition or abnormality.
- the diet and nutritional data (also referred to as diet and nutritional profile) systematically records the subscriber's dietary and nutritional intake and eating practices over time. For example, data may be obtained by periodically requesting information on what, how much, and when the subscriber ate and/or drank.
- the requests for information may target the time period of about 2 to about 8 hours preceding the request and the requests may be systematically timed so that every conscious hour may be eventually subjected to multiple requests for information.
- the subscriber's food intake including drinks and snacks) may be subjected to a comprehensive nutritional evaluation which establishes the nutritional value of the ingested substances including the amount and type of vitamins, minerals, calories, protein, carbohydrates, antioxidants, sodium, fats and the like.
- Each meal and snack (including drinks) is assessed and registered in order to construct a detailed, chronological image of the subscriber's dietary intake.
- This data may be subjected to pattern-analysis in order to identify repetitive patterns and associate fluctuations within the patterns to their influencing factors.
- the resulting diet and nutritional profile may be continuously updated in order to represent the subscriber's most current dietary intake.
- specific food and drink descriptions and quantities consumed are documented and used to identify dietary preferences and predispositions.
- the environmental exposure data consists of those environmental characteristics that describe both natural environmental considerations (i.e., natural occurrences such as outside air temperature, humidity, sunlight, naturally occurring toxic/hazardous emissions, terrain, rain, water temperature, and others), manmade or man influenced environments considerations (i.e., air conditioning, heating, ergonomics, lighting, pollution and contamination, traffic, and the like), and hazardous environments (i.e., intentional and unintentional manmade or man caused environmental considerations such as exposure to dangerous situations and dangerous substances such as nuclear materials, toxic or hazardous biological substances, and toxic or hazardous chemicals, and the like).
- natural environmental considerations i.e., natural occurrences such as outside air temperature, humidity, sunlight, naturally occurring toxic/hazardous emissions, terrain, rain, water temperature, and others
- manmade or man influenced environments considerations i.e., air conditioning, heating, ergonomics, lighting, pollution and contamination, traffic, and the like
- hazardous environments i.e., intentional and unintentional manmade or man caused environmental considerations such as exposure to dangerous situations
- the behavior data (also referred to as behavior profile) documents a variety of behaviors that are known to affect wellness and longevity.
- “behaviors” are strictly defined as the actions taken by a person to relax, deal with stress, and occupy free time.
- the behaviors, amount of time spent in these behaviors, and the degree or intensity in which the subscriber participates in a behavior may be registered.
- the behaviors may be divided into three general categories. The first category includes behaviors that involve taking a substance (alcohol, tobacco, drugs, food, coffee, and the like).
- the second category includes behaviors that require doing something (jogging, watching sports, gambling, watching TV, playing golf, conversations, sewing, and the like).
- the third category addresses coping impulses which include impulsive reactions to anger, affection, fear, confusion, and embarrassment.
- the data acquired may be subjected to a pattern-analysis to identify repetitive patterns and tendencies.
- the physiological characteristics data address the normal and abnormal performance characteristics of the subscriber's organ systems. These may include data such as vital signs, cardiovascular system, respiratory system, nervous system, skin system, musculoskeletal system, blood system, digestive system, endocrine system, urinary system, reproductive system and combinations comprising at least one of the foregoing for establishing unique characteristics and performance that may include visual acuity, blood pressure, heart rate and rhythm, respiratory rate, blood oxygen level, cholesterol levels, estrogen level, hearing acuity and sensitivity, sensory perception, PSA level, insulin levels, mental clarity, responsiveness, gait, posture, balance, teeth and gum condition, skin abnormalities, inflammation, pain, discomfort, discharges and the like.
- exemplary symptoms are somatic concern, anxiety, depressed mood, suicidality, guilt, hostility, aggression, elated mood, grandiosity, pressure of speech, suspiciousness/persecution, auditory or visual hallucinations, ideas of reference or control, unusual or playful thought content, thought disorder, playful behavior, self-neglect, self-harm, threats to others, disorientation, conceptual disorganization, blunted or flat affect, emotional withdrawal, apathy, social withdrawal, social anxiety, motor retardation, tension, uncooperativeness, excitement, inattention, distractibility, motor hyperactivity, mannerisms or posturing, movement disorder, delusions, poor rapport, passivity, poor abstract thinking, reduced or absent theory of mind, reduced insight, reduced judgment, reduced memory, anti-social traits, tendencies or
- the at least one attribute includes characteristics of certain receptors, such as serotonin receptors, dopamine receptors, estrogen receptors and adrenergic receptors in the subject.
- at least one attribute includes the one or more events, such as stroke, hypertension, diabetes, cardiovascular diseases, kidney disorders can cancer, in the subject's medical history.
- the method of determining the mental state of a subject comprises determining the mental competency to perform a function.
- the function concerns the capacity to operate a firearm.
- the function comprises operating a motor vehicle.
- the motor vehicle is an automobile. In other embodiments, the motor vehicle is an aircraft, boat or ship.
- the method comprises determining the mental state of a subject in order to determine whether the subject can purchase and/or possess a firearm, whether the subject possesses the mental capacity to safely operate a firearm, whether the subject has the mental capacity to safely own or operate a motor vehicle, or whether the subject's responses are contrary to other information previously supplied to other health professionals, law enforcement professionals, probation officials, immigration authorities or other governmental agencies.
- the mental state of the subject is determined based on the assessment score.
- a depression severity questionnaire is presented to the subject when the score indicates the presence of depression in the subject.
- the method further comprises collecting demographic information regarding the subject. This information may be used in the calculation of one or more of the assessment scores.
- the system may further include an alert database, which includes information concerning a number of mental states or behavioral disorders that can pose a danger to the subject, the subject's family, other people, as well as property.
- the alert may be related to a health danger such as, but not limited to, heart attack, stroke, aneurism, or dementia.
- the alert is related to the capacity to own or operate firearms or motor vehicles.
- the alert may relate to information contrary to information previously supplied by the subject to government authorities or agencies.
- the alert database includes a matrix for converting one or more responses to one or more questions in the assessment to generate one of more assessment scores for determining if the system should additionally send an automatic alert to one or more additional health professionals, law enforcement professionals, probation officials, motor vehicle licensing professionals, immigration officials, or a combination thereof.
- Each of assessment scores may be compared with a threshold score for activating the alert, wherein a score exceeding the threshold triggers activation of the alert.
- the alert is categorized into multiple levels e.g., level 1, level 2 and level 3 alert with level 3 alert being the most serious alert level.
- the alert level is color-coded, e.g., level blue, level orange and level red alert with level red alert being the most serious alert level.
- the alert is presented in the form of an alert signal on the computer screen for the health professionals' review.
- the alert level is listed as an item of an assessment report generated by the system for review by the health professionals.
- the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history triggers the system to present an automatic alert for review by the at least one health professional if the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history matches an alert event in the alert database.
- the system may further send an automatic alert to additional health professionals, law enforcement professionals, probation officials, motor vehicle licensing professionals, immigration authorities, or a combination thereof.
- the plurality of assessments are administered preferentially.
- the term “administered preferentially” means that a subsequent assessment is administered to the subject based upon an answer to a preceding assessment.
- the system is configured on a handheld device.
- the handheld device is a laptop computer, tablet computer, smartphone, or PDA.
- the method further comprises determining if the subject is undergoing an initial wellness assessment or a follow-up.
- the determined mental state can include any of the above-described disorders.
- the determined mental state is a behavioral disorder selected from the group consisting of depression, substance abuse, risk for bipolar disorder, and post-traumatic stress disorder.
- the system includes: a computer-readable memory, the computer-readable memory configured to store computer-executable instructions; an input device configured to receive an input from the subject; and a processor configured to execute the computer-executable instructions.
- the computer-executable instructions include prompting the subject with at least one question in a system for assessment of mental state on a display; recording at least one response to the at least one assessment, wherein the at least one response comprises a long-form answer; converting the at least one response into at least one assessment score; generating an output comprising the at least one assessment score for assessment of the mental state of the subject by at least one health professional; retrieving a medical history of the subject from a database and accepting at least one attribute from the medical history for the determination of the mental state of the subject, and/or presenting one or more questions about the medical history of the subject and receiving at least one response to the one or more questions about the medical history of the subject for the determination of the mental state of the subject, wherein the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history triggers the system to present an automatic alert for review by the at least one health professional if the at least one attribute from the medical history and/or the at least one response to the one or more questions about the
- the computer-executable instructions further comprise: a plurality of assessments; and the plurality of assessments is administered preferentially.
- the system is configured on a handheld device.
- the computer-executable instructions further comprise determining if the subject is undergoing an initial wellness assessment or a follow-up.
- the computer-executable instructions further comprise collecting demographic information regarding the subject.
- the diagnosed behavior disorder includes, or is caused by, a mental disorder or a behavioral disorder as described herein.
- the diagnosed behavioral disorders include at least one of depression, substance abuse, risk for bipolar disorder, and post-traumatic stress disorder.
- FIG. 1 is a block diagram illustrating exemplary hardware components that may be used for implementing aspects of the system and method for using a wellness assessment behavioral health kiosk 10 .
- a computer system 100 may include and execute programs to perform functions described herein, including steps of method described above. While only one processor 114 is shown in FIG. 1 , it is understood that the computer system 100 used to implement the wellness assessment behavioral health kiosk 10 may include multiple processors. Additionally, a system for implementing the wellness assessment behavioral health kiosk 10 may include multiple networked computer systems 100 . Further, a mobile device that includes some of the same components of computer system 100 may perform steps of the method described above.
- Computer system 100 may connect with a network 118 , e.g., Internet, or other network, to receive inquires, obtain data, and transmit information (e.g., to a user work station or other user computing device) as described above.
- a network 118 e.g., Internet, or other network
- Computer system 100 typically includes a memory 102 , a secondary storage device 112 , and a processor 114 .
- Computer system 100 may also include a plurality of processors 114 and be configured as a plurality of, e.g., bladed servers, or other known server configurations.
- Computer system 100 may also include an input device 116 , a display device 110 , and an output device 108 .
- Memory 102 may include RAM or similar types of memory, and it may store one or more applications for execution by processor 114 .
- Secondary storage device 112 may include a hard disk drive, floppy disk drive, CD-ROM drive, or other types of non-volatile data storage.
- Processor 114 may include multiple processors or include one or more multi-core processors. Any type of processor 114 capable of performing the calculations described herein may be used.
- Processor 114 may execute the application(s) that are stored in memory 102 or secondary storage 112 , or received from the Internet or other network 118 .
- the processing by processor 114 may be implemented in software, such as software modules, for execution by computers or other machines.
- These applications preferably include instructions executable to perform the functions and methods described above and illustrated in the Figures herein.
- the applications may provide graphic user interfaces (GUIs) through which users may view and interact with the application(s).
- GUIs graphic user interfaces
- processor 114 may execute one or more software applications in order to provide the functions described in this specification, specifically to execute and perform the steps and functions in the methods described above. Such methods and the processing may be implemented in software, such as software modules, for execution by computers or other machines.
- Input device 116 may include any device for entering information into computer system 100 , such as a touch-screen, keyboard, mouse, cursor-control device, microphone, digital camera, video recorder or camcorder. Input device 116 may be used to enter information into GUIs during performance of the methods described above.
- Display device 110 may include any type of device for presenting visual information such as, for example, a computer monitor or flat-screen display (or mobile device screen).
- Output device 108 may include any type of device for presenting a hard copy of information, such as a printer, and other types of output devices include speakers or any device for providing information in audio form.
- Examples of computer system 100 include dedicated server computers, such as bladed servers, personal computers, laptop computers, notebook computers, palm top computers, network computers, mobile devices, or any processor-controlled device capable of executing a web browser or other type of application for interacting with the system. If computer system 100 is a server, server 100 may not include input device 116 , display device 110 and output device 108 . Rather, server 100 may be connected, e.g., through a network connection to a stand-alone work station (another computer system) that has such devices.
- server 100 may not include input device 116 , display device 110 and output device 108 . Rather, server 100 may be connected, e.g., through a network connection to a stand-alone work station (another computer system) that has such devices.
- the system for using a wellness assessment behavioral health kiosk 10 may use multiple computer systems or servers as necessary or desired to support the users, as described above. Aspects may also use back-up or redundant servers to prevent network downtime in the event of a failure of a particular server.
- computer system 100 is depicted with various components, one skilled in the art will appreciate that the server can contain additional or different components.
- aspects of an implementation consistent with the above are described as being stored in memory, one skilled in the art will appreciate that these aspects can also be stored on or read from other types of computer program products or computer-readable media, such as secondary storage devices, including hard disks, floppy disks, or CD-ROM; or other forms of RAM or ROM.
- Computer-readable media may include instructions for controlling a computer system, such as the computer system 100 , to perform a particular method, such as methods described above.
- FIGS. 2A and 2B show a method 200 of using the wellness assessment behavioral health kiosk 10 , according to one aspect of this disclosure.
- the method 200 may begin by providing a welcome screen at block 202 to a user of the wellness assessment behavioral health kiosk 10 .
- the wellness assessment behavioral health kiosk 10 may prompt the user to select from, for example, two options.
- One option may be that the user is conducting her first wellness assessment and therefore, the user completes the full wellness assessment. Alternatively, the user may have already previously conducted a wellness assessment and is at the facility to conduct a follow-up visit.
- the method 200 may determine which option the user has selected. If the user selects the option of a follow-up visit, the method 200 may proceed to block 206 . If the user selects conducting an entire wellness assessment, the method 200 may proceed to block 210 .
- the method may prompt the user to complete a follow-up assessment.
- the follow-up assessment may ask the user a variety of questions related to the user.
- the follow-up assessment may ask the user questions about the user's progress. These questions may be tailored to the previous wellness assessment the user may have taken. For example, if the user had previously talked to her healthcare professional about an alcohol abuse problem, the method 200 may ask the user follow-up questions related to alcohol abuse. For example, the method 200 may ask the user if the user has decreased the amount of alcohol the user consumes per week or if she has sought additional help, for example, attending Alcoholics Anonymous meetings. These questions may be set without customization to the user. Alternatively, the questions may be tailored to the user based on, for example, notes previously made entered into the wellness kiosk by the user's healthcare professional. Once the user completes the follow-up questionnaire, the method 200 may proceed to block 208 .
- the method 200 may output the results of the follow-up questionnaire completed in block 206 .
- the method 200 may print the questions and answers of the follow-up questionnaire.
- the method 200 may output the results of the follow-up questionnaire electronically.
- the method 200 may output the results as an email to the user's healthcare professional.
- the method 200 may output the results to the user's electronic health records.
- the results may be incorporated into the user's preexisting electronic health records. If the user does not have a preexisting electronic health record, then the method may generate a new electronic health record for the user.
- the method 200 may continue to block 210 .
- the wellness assessment behavioral health kiosk 10 may prompt the user to enter demographic information.
- the demographic information may include, for example, the user's age, weight, height, ethnicity, gender, education, household composition, employment status, and other factors that may be useful in diagnosing the user.
- One of ordinary skill in the art would readily recognize that many other demographic aspects may be useful in diagnosing the user.
- the method 200 may proceed to block 212 .
- the wellness assessment behavioral health kiosk 10 may prompt the user to answer a series of behavioral questions.
- the wellness assessment behavioral health kiosk 10 may ask the user to complete a series of questions related to the frequency of depressed mood and anhedonia over a period of time.
- one common questionnaire used in diagnosing mental health conditions is the Patient Health Questionnaire-2 (PHQ-2).
- the PHQ-2 is used generally to screen for depressive behavior rather than a final diagnosis.
- the wellness assessment behavioral health kiosk 10 may ask the user about the user's frequency of depressed mood and anhedonia over the past two weeks. Based on the answers to the questions presented by the PHQ-2, the wellness assessment behavioral health kiosk 10 may assign a score to the user.
- the method 200 may proceed to block 214 .
- the wellness assessment behavioral health kiosk 10 may analyze the score generated in block 212 .
- the wellness assessment behavioral health kiosk 10 may have a minimum threshold for screening for depression.
- the wellness assessment behavioral health kiosk 10 may determine that the user may have depression if the score is equal to or higher than two.
- any threshold may be used. For example, the lower the threshold, the more sensitive the wellness assessment behavioral health kiosk 10 may be to detecting depressive behavior. Conversely, the higher the threshold, the less sensitive the wellness assessment behavioral health kiosk 10 may be to detecting depressive behavior. If the threshold in block 214 has not been met, then the method 200 may proceed to block 216 . If the threshold in block 214 has been met, then the method 200 may proceed to block 222 .
- the wellness assessment behavioral health kiosk 10 may ask the user to complete a post-traumatic stress disorder (PTSD) questionnaire.
- PTSD post-traumatic stress disorder
- the wellness assessment behavioral health kiosk 10 may ask the user questions from the primary care PTSD (PC-PTSD) screen.
- the PC-PTSD screen may include an introductory sentence or paragraph to cue respondents to traumatic events.
- the PC-PTSD screen may then ask a series of questions to the user to detect PTSD.
- the wellness assessment behavioral health kiosk 10 may generate a score.
- the method 200 may proceed to block 218 .
- the wellness assessment behavioral health kiosk 10 may analyze the generated PTSD questionnaire score to determine the likelihood that the user suffers from PTSD.
- the wellness assessment behavioral health kiosk 10 may have a minimum threshold for screening for PTSD.
- the wellness assessment behavioral health kiosk 10 may determine that the user may have PTSD if the score is equal to or higher than three.
- any threshold may be used. For example, the lower the threshold, the more sensitive the wellness assessment behavioral health kiosk 10 may be to detecting PTSD. Conversely, the higher the threshold, the less sensitive the wellness assessment behavioral health kiosk 10 may be to detecting PTSD. If the threshold in block 218 has not been met, then the method 200 may proceed to block 224 . If the threshold in block 218 has been met, then the method 200 may proceed to block 220 .
- the wellness assessment behavioral health kiosk 10 may ask the user to complete a second PTSD questionnaire.
- This second PTSD questionnaire may ask questions in more depth than the PTSD questionnaire in block 216 .
- the wellness assessment behavioral health kiosk 10 may ask questions that are found in the PTSD CheckList—Civilian Version.
- the wellness assessment behavioral health kiosk 10 may generate a score based on the answers the user provided to the questions.
- the method 200 may proceed to block 224 .
- the method 200 may proceed to block 222 .
- the wellness assessment behavioral health kiosk 10 may ask the user to complete a more in-depth depression severity questionnaire.
- the wellness assessment behavioral health kiosk 10 may ask the user to complete a Patient Health Questionnaire-9 (PHQ-9).
- the PHQ-9 may be used to screen, diagnose, monitor, and measure a severity of depression.
- the more in-depth depression severity questionnaire of block 222 may be a continuation of the questionnaire presented in block 212 .
- the wellness assessment behavioral health kiosk 10 may generate a score that represents, for example, whether the user exhibits depressive behavior and the severity of any depressive behavior.
- the method 200 may proceed to block 224 .
- the wellness assessment behavioral health kiosk 10 may ask the user to complete a bipolar risk factor questionnaire. For example, the wellness assessment behavioral health kiosk 10 may ask the user if the user had ever been diagnosed with bipolar disorder or had ever experienced a manic episode. Additionally, or alternatively, the wellness assessment behavioral health kiosk 10 may ask the user about the user's family history. For example, the wellness assessment behavioral health kiosk 10 may ask if any of the user's parents, siblings, or other ancestors had suffered from bipolar disorder or had ever experienced a manic episode. Additionally, or alternatively, the wellness assessment behavioral health kiosk 10 may ask the user for additional details regarding the subject's depression. For example, the wellness assessment behavioral health kiosk 10 may prompt the user for information, such as how suddenly the depression symptoms manifested.
- the wellness assessment behavioral health kiosk 10 may ask the user when the first depressive episode occurred. For example, the wellness assessment behavioral health kiosk may ask the user if the first depressive episode occurred before a certain age, such as eighteen years old. Once the user has answered these questions, the wellness assessment behavioral health kiosk 10 may generate a score based on the answers provided by the user. After block 224 is complete, the method 200 may proceed to block 226 .
- the wellness assessment behavioral health kiosk 10 may determine, based on the score generated in block 224 , whether the user should be further screened for a mood disorder. For example, the wellness assessment behavioral health kiosk 10 may have a minimum threshold for screening for bipolar disorder risk. For example, the wellness assessment behavioral health kiosk 10 may determine that the user may have bipolar disorder if the score is equal to or higher than one.
- any threshold may be used. For example, the lower the threshold, the more sensitive the wellness assessment behavioral health kiosk 10 may be to detecting bipolar disorder. Conversely, the higher the threshold, the less sensitive the wellness assessment behavioral health kiosk 10 may be to detecting bipolar disorder. If the threshold in block 226 has not been met, then the method 200 may proceed to block 230 . If the threshold in block 226 has been met, then the method 200 may proceed to block 228 .
- the wellness assessment behavioral kiosk 100 may ask the user additional questions related to the user's mood. After the user has answered the questions, the wellness assessment behavioral kiosk 100 may generate a score based on the answers. When block 228 is finished, the method 200 may proceed to block 230 .
- the wellness assessment behavioral kiosk 100 may ask the user pre-screening questions related to alcohol, drug, and tobacco use.
- the wellness assessment behavioral kiosk 100 may use the Screening, Brief Intervention, and Referral to Treatment (SBIRT) pre-screening questions.
- the SBIRT pre-screen may ask when the user last had a certain amount of drinks in a given period of time, such as four drinks in one day. Additionally, or alternatively, the SBIRT pre-screen may ask the user if the user has used drugs within a period of time, such as within the last twelve months. Additionally, or alternatively, the SBIRT pre-screen may ask the user if the user uses tobacco in any form.
- the wellness assessment behavioral kiosk 100 may store the answers. The stored answers may be used later in the method 200 , as described below.
- the method proceeds along path A, which continues on to FIG. 2B . Path A may branch into three different directions. For example, path A may continue to block 232 .
- the wellness assessment behavioral kiosk 100 may determine if the user has answered positively to alcohol. In other words, block 232 may determine if the user has used alcohol as described above with reference to block 230 . If the user is not positive for alcohol, then the method 200 may proceed to block 238 . However, if the user is positive for alcohol, then the method 200 may proceed to block 234 .
- the wellness assessment behavioral kiosk 100 may ask the user to complete an alcohol use disorders questionnaire.
- the alcohol use disorders questionnaire may be the Alcohol Use Disorders Identification Test (AUDIT).
- the wellness assessment behavioral kiosk 100 may use AUDIT to ask the user ten questions to gauge the user's alcohol consumption, drinking behaviors, and alcohol-related problems. Such questions may include questions regarding the frequency of alcohol use, the type of alcohol used, and whether the alcohol use has impaired the user's ability to function in day to day life.
- the wellness assessment behavioral kiosk may generate a score based on the answers the user provided in response to the alcohol use disorders questionnaire.
- the method 200 may proceed in two parallel paths. For example, in one of the parallel paths, the method 200 may proceed to block 238 . In the other parallel path, the method 200 may proceed to block 236 , which is analyzed in the context of both alcohol and drugs.
- the wellness assessment behavioral health kiosk 10 may ask the user to complete a set of resilience questions. Once the user has answered the resilience questions, the method 200 may proceed to block 240 .
- the wellness assessment behavioral health kiosk 10 may output the results of the wellness assessment.
- the method 200 may print the questions and answers of the assessment.
- the method 200 may output the results of the assessment electronically.
- the method 200 may output the results as an email to the user's healthcare professional.
- the method 200 may output the results to the user's electronic health records.
- the results may be incorporated into the user's preexisting electronic health records. If the user does not have a preexisting electronic health record, then the method may generate a new electronic health record for the user. The method 200 may then end.
- block 242 Another parallel path the method 200 may have taken after block 230 is block 242 , which determines if the user has answered positively for drugs. If the user has answered positively for drugs, the method 200 may proceed to block 244 .
- the wellness assessment behavioral kiosk 100 may ask the user to complete a drug abuse screening questionnaire.
- the drug abuse screening questionnaire may be the Drug Abuse Screening Test (DAST).
- the DAST may ask, for example, ten questions about the user's drug use in the past twelve months. The DAST asks only about drug use, not alcohol or tobacco.
- tests other than DAST may be used and that these other tests may ask questions about other behavior, including alcohol and tobacco use.
- the wellness assessment behavioral health kiosk may ask the user for what types of drugs the user uses, the frequency of use for each type of drug, the form in which the user uses the drug, and other questions designed to explore the user's drug use behavior.
- the method 200 may proceed to block 246 .
- the wellness assessment behavioral kiosk 100 may determine if the user has answered positively for both alcohol and drug use. If the user has answered positively for both alcohol and drug use, the method 200 may proceed to block 234 , as described above. However, if the user has not answered positively for both drugs and alcohol, the method 200 may proceed to block 248 .
- the wellness assessment behavioral kiosk 100 may ask the user to complete a set of resilience questions. These resilience questions may be the same as or similar to the resilience questions asked in block 238 , as described above. Once the user has completed block 248 , the method 200 may proceed to block 250 .
- the wellness assessment behavioral kiosk 100 may output the results of the wellness assessment.
- Block 250 is similar to block 240 , as described above.
- the method 200 may proceed directly to block 248 and then to block 250 , as described above.
- Another parallel path method 200 may take after block 230 is block 252 , which determines if the user has answered positively for tobacco use. If the user has indicated that the user uses tobacco, then the method 200 may proceed to block 254 .
- the method 200 may ask the user if the user is interested in quitting tobacco use. Once the user completes this block 254 , the method 200 may proceed to block 256 .
- the wellness assessment behavioral kiosk 100 may ask the user a series of resilience questions. These questions may be identical or similar to the resilience questions asked in blocks 238 and 248 . Once block 256 is completed, the method 200 may proceed to block 258 .
- the wellness assessment behavioral kiosk 100 may output the results of the wellness assessment.
- the wellness assessment behavioral kiosk 100 may output the results as described above in, for example, blocks 240 and 250 . However, if the user was not positive for tobacco at block 252 , then the method 200 may proceed directly to blocks 256 and then 258 , as described above. The method 200 may then end.
- the wellness assessment behavioral kiosk 100 may allow the user to input additional information.
- the questionnaire may allow the user to input sentences, short answers, or paragraphs to elaborate on the answers already given. In this way, the user is able to provide a more comprehensive answer that may provide nuance lost in the questionnaire.
- healthcare professionals may be able to specify certain important words or phrases in any of the longer responses provided by the user. For example, if the user provides, in a long for answer, that the user is contemplating suicide by using the word suicide, the wellness assessment behavioral kiosk 100 may be configured to highlight the word suicide in the outputted results. These important words or phrases may be generally applicable to all users of the wellness assessment behavioral kiosk 100 . Additionally, or alternately, the important words or phrases may be tailored for each user, based on previously provided answers or course of treatment. In this way, the healthcare professional may be quickly alerted to areas of particular concern.
- various blocks may generate a score based on the responses given by the user.
- the method 200 may then compare the generated score to various score thresholds.
- a score threshold may be pre-defined and unchangeable.
- the score threshold may be configurable by, for example, a healthcare professional.
- the score threshold may be tailored for each user. For example, if a user has shown in the past to be more vulnerable to alcohol abuse, the score threshold may be lower for this user to attempt to prevent the alcohol abuse from becoming worse.
- the score threshold may be dependent on demographic information. For example, if a user indicates that the user is divorced, the score threshold for that user for depressive behavior may be reduced.
- FIG. 3 shows another exemplary method 300 of using the wellness assessment behavioral health kiosk 10 .
- the method 300 may begin at block 302 .
- the wellness assessment behavioral health kiosk 10 may receive input from a user in response to a mental competency assessment.
- the wellness assessment behavioral health kiosk 10 may receive input from the user in response to various assessments, such as the assessments described above, for example, in blocks 204 , 206 , 210 , 212 , 216 , 220 , 222 , 224 , 228 , 230 , 234 , 238 , 244 , 248 , 252 , and 254 in method 200 .
- the method 300 may proceed to block 304 .
- the wellness assessment behavioral health kiosk 10 may transmit the user input gathered in block 302 to a healthcare professional. While FIG. 3 shows that block 304 follows block 302 , one of ordinary skill in the art would readily recognize that the wellness assessment behavioral health kiosk 10 may transmit the inputted information as the user inputs the information or it may transmit the inputted information once all of the information has been gathered.
- the user input may be transmitted to another device, such as a computer located near a healthcare professional.
- any device capable of receiving such information may receive the transmitted information.
- the user input may be transmitted over a network, such as network 118 .
- the healthcare professional may be, for example, a primary physician. There may also be more than one healthcare professional.
- the information may be transmitted to multiple healthcare professionals who may analyze the information jointly. Based on the analysis, the one or more healthcare professionals may generate a recommendation based on the transmitted information.
- the recommendation may include the mental competency of the user.
- the recommendation may also include a treatment plan.
- the wellness assessment behavioral health kiosk 10 may receive the recommendation generated in block 304 .
- the recommendation generated in block 304 may be transmitted to the wellness assessment behavioral health kiosk 10 using, for example, a computer located near the healthcare professional.
- a computer located near the healthcare professional One of ordinary skill in the art would readily recognize that any device capable of transmitting such information may transmit the recommendation.
- the recommendation may be transmitted over a network, such as network 118 .
- the method 300 may continue to block 308 .
- the wellness assessment behavioral health kiosk 10 may output the recommendation received in block 306 .
- the output may presented to the user who input information into the wellness assessment behavioral health kiosk 10 .
- the output may be presented to a third party.
- the outputted recommendation may include a course of treatment.
- Another aspect of the present application relates to a method for treating a behavioral disorder in a subject in need thereof.
- the method includes the steps of: prompting the subject with at least one question on a display of a system for assessment of a behavioral disorder of the subject, wherein the system comprises the display, an input device, a processer and a database; recording at least one response to the system, wherein the at least one response comprises a long-form answer; analyzing the at least one response by at least one health professional; determining by the at least one health professional, based on the at least one response, the behavioral disorder of the subject; and incorporating the behavioral disorder of the subject into an electronic health record associated with the subject.
- the method further comprises administering to the subject at least one treatment effective for the behavioral disorder.
- the method further comprises the step of retrieving a medical history of the subject from a database and accepting the at least one attribute from the medical history for the determination of the behavioral disorder of the subject. In some embodiments, the method further comprises the step of presenting one or more questions about the medical history of the subject and receiving responses to the one or more questions about the medical history of the subject for the determination of the behavioral disorder of the subject.
- the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history triggers an automatic alert for review by the at least one health professional if the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history matches an alert event in an alert database.
- the method comprises analyzing the at least one response by two health professionals.
- the at least one health professional is a mental health professional.
- the mental health professional is a psychiatrist.
- the at least one health professional is a physician.
- the two health professionals are a physician and a mental health professional.
- the method further comprises the step of converting the at least one response into an assessment score based on a matrix.
- the therapeutic regimes can include treatment with pharmacological compounds that modulate the brain's serotonin and/or norepinephrine systems.
- pharmacological compounds include, but are not limited to, tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRI), selective norepinephrine reuptake inhibitors (SNRI), and serotonin antagonist and reuptake inhibitors (SARI).
- exemplary pharmacological compounds include amitriptyline (ELAVILTM), clomipramine (ANAFRANILTM), desipramine (NORPRAMINTM), doxepin (SINEQUANTTM), imipramine (TOFRANILTM), nortriptyline (PAMELORTTM), protriptyline (VIVACTILTM), fluoxetine (PROZACTM), fluvoxamine (LUVOXTM), paroxetine (PAXILTM), sertaline (ZOLOFTTM), citalopram (CELEXATM), escitalopram oxalate (LEXAPROTM) duloxetine (CYMBALTATM) venlafaxine (EFFEXORTM), mirtazapine (REMERONTM), nefazodone (SERZONETM), and desyrel (TRAZODONETTM).
- the foregoing pharmacological compounds can be used singly or in any combination. The foregoing list of exemplary compounds is not exhaustive of those known in
- Non-pharmacological therapeutic regimes include, for example, psychotherapy, including exposure-based psychotherapy, cognitive psychotherapy, and psycho-dynamically oriented psychotherapy; electroconvulsive therapy (ECT).
- psychotherapy including exposure-based psychotherapy, cognitive psychotherapy, and psycho-dynamically oriented psychotherapy; electroconvulsive therapy (ECT).
- ECT electroconvulsive therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Developmental Disabilities (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Social Psychology (AREA)
- Physiology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Educational Technology (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A method and system for assessing the mental state or behavioral disorder of a subject is disclosed. The system includes a display, an input device, a processor, a database and matrix for converting the responses to one or more assessment scores. The disclosure also relates to a method for treating a behavioral disorder using the method and a system described herein.
Description
- This application is a division of U.S. application Ser. No. 15/295,489, filed Oct. 17, 2016. The entirety of the aforementioned applications is incorporated herein by reference.
- This disclosure is generally related to systems and methods for assessing health. More specifically, this disclosure is related to systems and methods for assessing or determining a mental state of a subject using a kiosk.
- The 16th Surgeon General's report on mental health reported that mental health is fundamental and that mental disorders are real health conditions. However, since that report, systems for addressing mental disorders remain challenging and often provide unequal opportunities and unequal outcomes.
- One aspect of assessing or determining a mental state of a subject is that health care professionals have a limited time with each subject to collect information and provide medical services and/or guidance. In collecting information, behavioral health and social history are often missed. These are often missed because they are more time-consuming to collect and the answers are often more sensitive. Moreover, research has shown that subjects are more likely to disclose sensitive information to a computer rather than to staff. Subjects also often spend a considerable amount of time in a waiting room to see a health care professional. Having subjects provide behavioral health and social history information while they are waiting would increase the efficiency of health care delivery.
- Accordingly, there is a need for systems and methods to collect behavioral health and social history information in a sensitive and effective manner to increase efficiency of health care delivery.
- The present application fulfills a need for a system and method for collecting information from a subject for mental health evaluation of the information by healthcare professionals to determine the mental competency of the subject and/or the need for treatment of a subject for a behavioral disorder.
- One aspect of the present application relates to a method for assessment of a mental state of a human subject. The method includes the steps of: prompting the subject with at least one question on a display of a system for assessment of the mental state of the subject; recording at least one response to the at least one question in the system; calculating an assessment score based on the at least one response; determining by at least one health professional, based on the at least one response and/or the assessment score, the mental state of the subject; and incorporating the mental state of the subject into an electronic health record associated with the subject, wherein the at least one response comprises a long-form answer and wherein the system comprises the display, an input device, a processer, a database and a matrix for converting the at least one response to an assessment score.
- Another aspect of the present application relates to a method for treating a behavioral disorder in a subject in need thereof. The method comprises the steps of: prompting the subject with at least one question on a display of a system for assessment of a behavioral disorder of the subject, wherein the system comprises the display, an input device, a processer and a database; recording at least one response to the system, wherein the at least one response comprises a long-form answer; analyzing the at least one response by at least one health professional; determining by the at least one health professional, based on the at least one response, the mental state or behavioral disorder of the subject; and incorporating the mental state or behavioral disorder of the subject into an electronic health record associated with the subject. The method further comprises administering to the subject at least one treatment effective for the behavioral disorder. By incorporating the mental state or behavioral state of the subject in an electronic health record, the present application provides a means for alerting authorities concerning potential dangers or risks associated with owning and/or operating firearms, motor vehicles, etc.
- In some embodiments, the method further comprises the step of retrieving a medical history of the subject from a database and accepting the at least one attribute from the medical history for the determination of the mental state or behavioral disorder of the subject. In some embodiments, the method further comprises the step of presenting one or more questions about the medical history of the subject and receiving responses to the one or more questions about the medical history of the subject for the determination of the mental state or behavioral disorder of the subject.
- In some embodiments, the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history triggers an automatic alert for review by the at least one health professional if the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history matches an alert event in an alert database.
- Still another aspect of the present application relates to a system for assessing the mental state of a subject. The system comprises: a computer-readable memory, the computer-readable memory configured to store computer-executable instructions; an input device configured to receive an input from the subject; and a processor configured to execute the computer-executable instructions, the computer-executable instructions comprising: prompting the subject with at least one question in a system for assessment of mental state on a display; recording at least one response to the at least one assessment, wherein the at least one response comprises a long-form answer; converting the at least one response into at least one assessment score; generating an output comprising the at least one assessment score for assessment of the mental state of the subject by at least one health professional, generating a report of the mental state of the subject based on the assessment by the at least one health professional and incorporating the report into an electronic health record associated with the subject.
- In some embodiments, the processor is configured to execute additional computer-executable instructions, including the step of retrieving a medical history of the subject from a database and accepting the at least one attribute from the medical history for the determination of the mental state of the subject. In some embodiments, the processor is configured to execute additional computer-executable instructions, including the step of presenting one or more questions about the medical history of the subject and receiving responses to the one or more questions about the medical history of the subject for the determination of the mental state of the subject.
- In some embodiments, the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history triggers the system to present an automatic alert for review by the at least one health professional if the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history matches an alert event in an alert database.
- In some embodiments, the system further comprises a database of alert events, wherein a response to the at least one question, and/or an attribute of a medical history of the subject, triggers the system to present an automatic alert for review by the at least one health professional if the response and/or the attribute matches an alert event in the database.
- The present invention can be better understood by reference to the following drawings, wherein like references numerals represent like elements. The drawings are merely exemplary to illustrate certain features that may be used singularly or in any combination with other features and the present invention should not be limited to the embodiments shown.
-
FIG. 1 is a block diagram illustrating exemplary hardware components that may be used for implementing aspects of the system. -
FIGS. 2A and 2B show an exemplary method of using the wellness assessment behavioral health kiosk. -
FIG. 3 shows another exemplary method of using the wellness assessment behavioral health kiosk. - The following detailed description is presented to enable any person skilled in the art to make and use the object of this application. For purposes of explanation, specific nomenclature is set forth to provide a thorough understanding of the present application. However, it will be apparent to one skilled in the art that these specific details are not required to practice the subject of this application. Descriptions of specific applications are provided only as representative examples. The present application is not intended to be limited to the embodiments shown, but is to be accorded the widest possible scope consistent with the principles and features disclosed herein.
- This description is intended to be read in connection with the accompanying drawings, which are to be considered part of the entire written description of this application. The drawing figures are not necessarily to scale and certain features of the application may be shown exaggerated in scale or in somewhat schematic form in the interest of clarity and conciseness.
- As used herein, the term “mental health” relates to the psychological well-being of a subject. According to the World Health Organization (WHO), mental health includes “subjective well-being, perceived self-efficacy, autonomy, competence, inter-generational dependence, and self-actualization of one's intellectual and emotional potential, among others” (World Health Organization, “World Health Report 2001: Mental Health: New Understanding, New Hope,” 2001). The WHO further states that the well-being of an individual is encompassed in the realization of their abilities, coping with normal stresses of life, productive work and contribution to their community.
- As used herein, the terms “mental illness,” “mental disorder”, “behavioral disorder” and “psychiatric disorder” relate to mental health conditions comprising a disorder in the mood, thinking or behavior of a subject. Mental illnesses or behavioral disorders commonly present with cognitive deficits and mood dysregulation. Mental illnesses or behavioral disorders are generally defined by a combination of how a person feels, acts, thinks or perceives. Well established systems for the classification of mental illnesses or behavioral disorders include the International Statistical Classification of Diseases and Related Health Problems, 10th Revision (World Health Organization, tenth revision (2010), the content of which is hereby expressly incorporated by reference in its entirety for all purposes) and the Diagnostic and Statistical Manual of Mental Disorders (fifth edition, DSM-5; American Psychiatric Association, (2013), the content of which is hereby expressly incorporated by reference in its entirety for all purposes). Common examples of mental illnesses or behavioral disorders include schizophrenia, Alzheimer's disease, Huntington's disease, Cushing's disease, Lewy body disease, multiple sclerosis, stroke, addictive disorder, pervasive development disorder, autism, fragile X syndrome, anxiety disorder, mood disorders, Prader-Willi syndrome, bipolar disorder, depressive disorders, behavioral disorders, eating disorders, vascular dementia, mild cognitive impairment, autism, dementia and delirium. The mental illnesses or behavioral disorders also include an organic mental disorder, a mental or behavioral disorder caused by psychoactive substance use, a schizophrenia, schizotypal, or delusional disorder, a mood (affective) disorder, neurotic, stress-related, or somatoform disorder, a behavioral syndrome, an adult personality or behavior disorder, a psychological development disorder, or a child onset behavioral or emotional disorders.
- Depressive disorders affect over fifteen percent (15%) of the population. Depression is a mental state of depressed mood characterized by feelings of sadness, despair, and discouragement. Depression includes the normal feelings of “the blues” through dysthymic disorder to major depressive disorder. Dysthymic disorder is a mood disorder characterized by depressed feeling (sad, blue, low), loss of interest or pleasure in usual activities, and at least some of the following: changes in appetite and sleep patterns, lack of energy, low self-esteem, poor concentration or decision-making skills, and feelings of hopelessness. In dysthymic disorders, symptoms have persisted for more than two years but are not severe enough to meet the criteria for major depressive disorder. Major depressive disorder is characterized by major depressive episodes, a period of daily depressed mood or loss of interest or pleasure in almost all activities with some combination of the following symptoms: altered appetite, weight, or sleep patterns, psychomotor agitation or retardation, diminished capacity for thinking, concentration, or decisiveness, lack of energy and fatigue, feelings of worthlessness, self-reproach, or guilt, frequent thoughts of death or suicide, plans or attempts to commit the latter (Diagnostic and Statistical Manual of Mental Disorders, 4th ed., American Psychiatric Association, Washington D.C., 1994).
- As used herein, the term “behavioral disorder” relates to a disorder characterized by displayed behaviors over a long period of time which significantly deviate from socially acceptable norms for a person's age and situation. Exemplary behavioral disorders include, but are not limited to, anxiety disorders (including post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), generalized anxiety disorder, and panic disorder), disruptive disorders, dissociative disorders, emotional disorders, pervasive developmental disorders and substance abuse. In some embodiments, the behavior disorder includes, or is caused by, a mental disorder or a behavioral disorder.
- As used herein, the term “mental competency” relates to the ability of a subject to act in the circumstances, including the ability to perform a task, job or occupation, or to reason or make decisions. A subject's mental competency can be assessed by the present method and system to determine, for example, whether the subject should be allowed to purchase a firearm, or whether the subject can perform a job function, such as a pilot. Accordingly, a system of the present application can be made available at point of service locations including, but not limited to, retail establishments, medical facilities or offices, or employment agencies/offices.
- As used herein, the term “assessment” relates to determination of the mental state of a subject, determination of changes in the mental state of a subject, determination/diagnosis of a mental illness in a subject or determination/diagnosis of changes in a mental illness in a subject.
- As used herein, the term “long-form answer” relates to an answer to a question that is more than a single word answer such as, yes, no, maybe, true or false.
- As used herein, the term “subject” relates to a human individual or subject in need of analysis of a mental state for mental competency or diagnostic purposes.
- As used herein, the terms “health professional” or “healthcare provider” relate to an individual who provides preventive, curative, promotional or rehabilitative health care services in a systematic way to people, families or communities. Health professionals include, but are not limited to, physicians, psychiatrists, psychologists, pharmacists, physician assistants, nurses, nurse practitioners, advanced practice registered nurses, surgeons, surgeon's assistant, therapists, chiropractors, clinical officers, social workers, operating department practitioners, and a wide variety of other human resources trained to provide some type of health care service.
- As used herein, the terms “physician” or “medical doctor” relate to a professional who practices medicine, and is concerned with promoting, maintaining, or restoring health through the study, diagnosis, and treatment of disease, injury, and other physical and mental impairments. A physician may include, but is not limited to, a primary care physician of a subject; a staff physician in a hospital, nursing home, clinic or other medical care facility; a physician who is a member of a medical group; a general practitioner; a Doctor of Osteopathic Medicine or a family physician. In some embodiments, the term “physician” does not include a psychiatrist or a psychologist.
- As used herein, the term “mental health professional” relates to a health care practitioner or community services provider who offers services for the purpose of improving an individual's mental health or to treat mental illness. A mental health professional includes, but is not limited to, a psychiatrist and a psychologist.
- One aspect of the present application relates to a method for assessment of a mental state of a human subject. The method comprises the steps of: prompting the subject with at least one question on a display of a system for assessment of the mental state of the subject; recording at least one response to the at least one question in the system; calculating an assessment score based on the at least one response; determining by at least one health professional, based on the at least one response and/or the assessment score, the mental state of the subject; and incorporating the mental state of the subject into an electronic health record associated with the subject, wherein the at least one response comprises a long-form answer and wherein the system comprises the display, an input device, a processer, a database and a matrix for converting the at least one response to an assessment score.
- In some embodiments, the method further comprises the step of retrieving a medical history of the subject from a database and accepting the at least one attribute from the medical history for the determination of the mental state of the subject. In some embodiments, the method further comprises the step of presenting one or more questions about the medical history of the subject and receiving responses to the one or more questions about the medical history of the subject for the determination of the mental state of the subject.
- In some embodiments, the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history triggers an automatic alert for review by the at least one health professional if the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history matches an alert event in an alert database.
- In some embodiments, the method comprises analyzing the at least one response by two health professionals. In some further embodiments, the at least one health professional is a mental health professional. In some still further embodiments, the mental health professional is a psychiatrist. In other further embodiments, the at least one health professional is a physician. In some yet further embodiments, the two health professionals are a physician and a mental health professional.
- In some embodiments, the assessment of a mental state includes the determination or diagnosis of a mental illness or a behavioral disorder.
- In some embodiments, the mental illness or a behavioral disorder is caused or related to a disorder of the central nervous system. As used herein, the terms “disorder of the central nervous system”, “central nervous system disorder”, “CNS disorder”, and the like refer to a disorder affecting either the spinal cord (e.g., a myelopathy) or brain (e.g., an encephalopathy) of a subject, which commonly presents with neurological and/or psychiatric symptoms. CNS disorders include many neurodegenerative diseases (e.g., Huntington's disease, Amyotrophic lateral sclerosis (ALS), hereditary spastic hemiplegia, primary lateral sclerosis, spinal muscular atrophy, Kennedy's disease, Alzheimer's disease, ataxias, Huntington's disease, Lewy body disease, a polyglutamine repeat disease, and Parkinson's disease) and behavioral disorders (e.g., mood disorders, schizophrenias, and autism). Non-limiting examples of ataxia include Friedreich's ataxia and the spinocerebellar ataxias. Specifically for this application, CNS disorders do not include disorders resulting from acute viral and bacterial infections.
- Non-limiting examples of CNS disorders include neurodegenerative disorders of the central nervous system, systemic atrophies primarily affecting the central nervous system, extrapyramidal and movement disorders, demyelinating disorders of the central nervous system, episodic or paroxysmal disorders of the central nervous system, paralytic syndromes of the central nervous system, nerve, nerve root, or plexus disorders of the central nervous system, organic mental disorders, mental or behavioral disorders caused by psychoactive substance use, schizophrenic, schizotypal, or delusional disorders, mood (affective) disorders, neurotic, stress-related, or somatoform disorders, behavioral syndromes, adult personality or behavior disorders, psychological development disorders, and child onset behavioral or emotional disorders. (Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5, 2013); The World Health Organization, The International Classification of Diseases, 10th revision (ICD-10), Chapter V.
- In some embodiments, the mental illness or behavioral disorder is caused by neurodegenerative CNS disorders. Neurodegenerative CNS disorders are typically characterized by progressive dysfunction and/or cell death in the central nervous system. The hallmark of many neurodegenerative CNS disorders is the accumulation of misfolded proteins, such as beta-amyloid, tau, alpha-synuclein, and TDP-43, both intracellularly and extracellularly. Many neurodegenerative diseases are also associated with gross mitochondrial dysfunction. Common examples of neurodegenerative CNS disorders include Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease, and Amyotrophic lateral sclerosis (ALS), a circumscribed brain atrophy (e.g., Pick's disease); senile degeneration of brain; a degeneration of nervous system due to alcohol; grey-matter degeneration (e.g., Alpers' disease); Lewy body dementia, subacute necrotizing encephalopathy (e.g., Leigh's disease); and subacute combined degeneration of spinal cord.
- In some embodiments, the mental illness or behavioral disorder is caused by CNS disorders selected from the group consisting of a systemic atrophy primarily affecting the central nervous system, an extrapyramidal and movement disorder, a neurodegenerative disorder of the central nervous system, a demyelinating disorder of the central nervous system, an episodic or paroxysmal disorder of the central nervous system, a paralytic syndrome of the central nervous system, a nerve, nerve root, or plexus disorder of the central nervous system.
- Non-limiting examples of systemic atrophies that primarily affect the central nervous system include: Huntington's disease; hereditary ataxias (e.g., congenital non-progressive ataxia, early-onset cerebellar ataxias—such as early-onset cerebellar ataxia with essential tremor, Hunt's ataxia, early-onset cerebellar ataxia with retained tendon reflexes, Friedreich's ataxia, and X-linked recessive spinocerebellar ataxia—late-onset cerebellar ataxia, ataxia telangiectasia (Louis-Bar syndrome), or hereditary spastic paraplegia); a spinal muscular atrophy or related disorder thereof (e.g., Werdnig-Hoffman disease (Type 1), progressive bulbar palsy of childhood (Fazio-Londe syndrome), Kugelberg-Welander disease (Type 3), or a motor neuron disease—such as familial motor neuron disease, amyotrophic lateral sclerosis (ALS), primary lateral sclerosis, progressive bulbar palsy, and progressive spinal muscular atrophy); paraneoplastic neuromyopathy and neuropathy; systemic atrophy primarily affecting the central nervous system in neoplastic disease; paraneoplastic limbic encephalopathy; and systemic atrophy primarily affecting the central nervous system in myxedema.
- In some embodiments, the mental illnesses or behavioral disorders are caused by the CNS disorder selected from the group consisting of Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis (ALS), Huntington's disease, cerebral palsy, bipolar disorder, schizophrenia, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS), or Pediatric acute-onset neuropyschiatric syndrome (PANS).
- In some embodiments, the mental illness or behavioral disorder is caused by an extrapyramidal and movement disorder. Non-limiting examples of extrapyramidal and movement disorders that affect the central nervous system include: Parkinson's disease; a secondary parkinsonism (e.g., malignant neuroleptic syndrome or postencephalitic parkinsonism); a degenerative disease of the basal ganglia (e.g., Hallervorden-Spatz disease, progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski disease), or striatonigral degeneration), a dystonia (e.g., drug-induced dystonia, idiopathic familial dystonia, idiopathic non-familial dystonia, spasmodic torticollis, idiopathic orofacial dystonia—such as orofacial dyskinesia—or blepharospasm); an essential tremor; a drug-induced tremor, myoclonus, drug-induced chorea, drug-induced tics; restless legs syndrome; and stiff-man syndrome.
- In some embodiments, the mental illness is dementia. In certain embodiments, the dementia is a cortical dementia (associated, for example, with Alzheimer's) arising from a disorder affecting the cerebral cortex. In certain embodiments, the dementia is a subcortical dementia (associated, for example, with Parkinson's disease and Huntington's disease) resulting from dysfunction in the parts of the brain that are beneath the cortex. In certain embodiments, the dementia is a side effect of drug administration. In specific embodiments, the dementia is a side effect of the administration of a chemotherapeutic agent. In specific embodiments, the dementia is a result of undergoing cardiac bypass. In specific embodiments, the dementia is a result of a vascular disorder (e.g., myocardial infarction, stroke, high blood pressure). In specific embodiments, the dementia is a result of depression.
- In some embodiments, the mental illness or behavioral disorder is caused by a demyelinating disorder of the central nervous system. Non-limiting examples of demyelinating disorders that affect the central nervous system include: multiple sclerosis; an acute disseminated demyelination disorder (e.g., neuromyelitis optica (Devic's syndrome) or acute and subacute hemorrhagic leukoencephalitis (Hurst's disease)); diffuse sclerosis; central demyelination of corpus callosum; central pontine myelinolysis; acute transverse myelitis in demyelinating disease of central nervous system; subacute necrotizing myelitis; and concentric sclerosis (Balo disease).
- In some embodiments, the mental illness or behavioral disorder is caused by an episodic or paroxysmal disorder of the central nervous system. Non-limiting examples of episodic and paroxysmal disorders that affect the central nervous system include: epilepsy (e.g., localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures; localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures; a benign epileptic syndrome—such as myoclonic epilepsy in infancy and neonatal convulsions (familial)—childhood absence epilepsy (e.g., pyknolepsy), epilepsy with grand mal seizures on awakening, a juvenile epilepsy—such as absence epilepsy or myoclonic epilepsy (impulsive petit mal)—a nonspecific epileptic seizure—such as an atonic, clonic, myoclonic, tonic, or tonic-clonic epileptic seizure, epilepsy with myoclonic absences or myoclonic-astatic seizures, infantile spasms, Lennox-Gastaut syndrome, Salaam attacks, symptomatic early myoclonic encephalopathy, West's syndrome, epilepsia partialis continua (Kozhevnikov epilepsy), grand mal seizures, or petit mal); headaches (e.g., a migraine—such as a migraine without aura (common migraine), a migraine with aura (classical migraine), status migrainosus, and complicated migraine—cluster headache syndrome, a vascular headache, a tension-type headache, a chronic post-traumatic headache, or a drug-induced headache); a cerebrovascular episodic or paroxysmal disorder (e.g., a transient cerebral ischaemic attacks or related syndrome—such as vertebrobasilar artery syndrome, carotid artery syndrome (hemispheric), a multiple and bilateral precerebral artery syndrome, amaurosis fugax, and transient global amnesia—a vascular syndrome of the brain—such as middle cerebral artery syndrome, anterior cerebral artery syndrome, posterior cerebral artery syndrome, a brain stem stroke syndrome (e.g., Benedikt syndrome, Claude syndrome, Foville syndrome, Millard-Gubler syndrome, Wallenberg syndrome, or Weber syndrome), cerebellar stroke syndrome, pure motor lacunar syndrome, pure sensory lacunar syndrome, or a lacunar syndromes); and a sleep disorder (e.g., insomnia, hyperinsomnia, a disruption in circadian rhythm, sleep apnea, narcolepsy, or cataplexy).
- In some embodiments, the mental illness or behavioral disorder is caused by a CNS disorder is a paralytic syndrome of the central nervous system. Non-limiting examples of paralytic syndromes that affect the central nervous system include: a cerebral palsy (e.g., spastic quadriplegic cerebral palsy, spastic diplegic cerebral palsy, spastic hemiplegic cerebral palsy, dyskinetic cerebral palsy, or ataxic cerebral palsy); a hemiplegia (e.g., flaccid hemiplegia or spastic hemiplegia); a paraplegia or tetraplegia (e.g., flaccid paraplegia, spastic paraplegia, paralysis of both lower limbs, lower paraplegia, flaccid tetraplegia, spastic tetraplegia, or quadriplegia); diplegia of upper limbs; monoplegia of a lower limb, monoplegia of an upper limb; cauda equina syndrome; and Todd's paralysis (postepileptic).
- In some embodiments, the mental illness or behavioral disorder is caused by an otherwise classified disorder of the central nervous system. Non-limiting examples of these disorders include: hydrocephalus; a toxic encephalopathy, a cerebral cyst; anoxic brain damage; benign intracranial hypertension; postviral fatigue syndrome; an encephalopathy; compression of brain; cerebral oedema; Reye's syndrome; postradiation encephalopathy; traumatic brain injury; syringomyelia; syringobulbia; a vascular myelopathy; spinal cord compression; myelopathy; a cerebrospinal fluid leak; a disorder of the meninges (e.g., cerebral or spinal meningeal adhesion); and a post-procedural disorder of nervous system (e.g., cerebrospinal fluid leak from spinal puncture, an adverse reaction to a spinal or lumbar puncture, or intracranial hypotension following ventricular shunting).
- In some embodiments, the mental illness is an organic mental disorder. Non-limiting examples of organic mental disorders that affect the central nervous system include: dementia (e.g., dementia associated with Alzheimer's disease, Pick's disease, Creutzfeldt-Jakob disease, Huntington's disease, Parkinson's disease, or human immunodeficiency virus (HIV) disease, or vascular dementia—such as multi-infarct dementia); organic amnesic syndrome not induced by alcohol and other psychoactive substances); delirium not induced by alcohol and other psychoactive substances; a mental disorder due to brain damage and dysfunction and to physical disease (e.g., organic hallucinosis, organic catatonic disorder, organic delusional (schizophrenia-like) disorder, organic mood (affective) disorder, organic anxiety disorder, organic dissociative disorder; organic emotionally labile (asthenic) disorder; a mild cognitive disorder, or organic brain syndrome); and a personality and behavioral disorders due to brain disease, damage and dysfunction (e.g., organic personality disorder, postencephalitic syndrome, or postconcussional syndrome).
- In some embodiments, the mental illness or behavioral disorder is a mental or behavioral disorder caused by psychoactive substance use. Non-limiting examples of mental or behavioral disorders caused by psychoactive substance use that affect the central nervous system include: acute intoxication (e.g., from alcohol, opioid, cannabis, benzodiazepine, or cocaine use); a dependence syndrome (e.g., from alcohol, opioid, cannabis, benzodiazepine, cocaine, or nicotine addiction); a withdrawal syndrome (e.g., an alcohol or benzodiazepine withdrawal syndrome); delirium tremens; and a psychotic disorder (e.g., alcoholic hallucinosis or stimulant psychosis); an amnesic syndrome (e.g., Korsakoff s syndrome); a residual and late-onset psychotic disorder (e.g., posthallucinogen perception disorder).
- In some embodiments, the mental illness or behavioral disorder is an autism spectrum disorder. In certain embodiments, the CNS disorder is autism, Asperger syndrome, pervasive developmental disorder not otherwise specified (PDD-NOS), childhood disintegrative disorder, or Rett syndrome.
- In some embodiments, the mental illness or behavioral disorder is a schizophrenia, schizotypal, or delusional disorder. Non-limiting examples of schizophrenia, schizotypal, and delusional disorders that affect the central nervous system include: schizophrenia (e.g., paranoid schizophrenia, hebephrenic schizophrenia (disorganized schizophrenia), catatonic schizophrenia, undifferentiated schizophrenia, post-schizophrenic depression, residual schizophrenia, simple schizophrenia, cenesthopathic schizophrenia, schizophreniform disorder, or schizophreniform psychosis); schizotypal disorder; a persistent delusional disorder (e.g., delusional disorder, delusional dysmorphophobia, involutional paranoid state, or paranoia querulans); an acute or transient psychotic disorder (e.g., acute polymorphic psychotic disorder without symptoms of schizophrenia, acute polymorphic psychotic disorder with symptoms of schizophrenia, or acute schizophrenia-like psychotic disorder); an induced delusional disorder (e.g., folie a deux, induced paranoid disorder, or induced psychotic disorder); a schizoaffective disorder (e.g., manic type, depressive type, or mixed type schizoaffective disorder); and chronic hallucinatory psychosis.
- In some embodiments, the mental illness or behavioral disorder is a mood (affective) disorder. Non-limiting examples of mood (affective) disorders that affect the central nervous system include: a manic episode (e.g., hypomania, mania without psychotic symptoms, or mania with psychotic symptoms); a bipolar affective disorder (e.g., bipolar affective disorder—current episode hypomanic, bipolar affective disorder—current episode manic without psychotic symptoms, bipolar affective disorder—current episode manic with psychotic symptoms, bipolar affective disorder—current episode mild or moderate depression, bipolar affective disorder—current episode severe depression without psychotic symptoms, bipolar affective disorder—current episode severe depression with psychotic symptoms, bipolar affective disorder—current episode mixed, bipolar affective disorder—currently in remission, bipolar II disorder, or recurrent manic episodes); a depressive episode (e.g., mild depressive episode, moderate depressive episode, severe depressive episode without psychotic symptoms, severe depressive episode with psychotic symptoms, atypical depression, or single episodes of “masked” depression); a recurrent depressive disorder (e.g., recurrent depressive disorder—current episode mild, recurrent depressive disorder—current episode moderate, recurrent depressive disorder—current episode severe without psychotic symptoms, recurrent depressive disorder—current episode severe with psychotic symptoms, or recurrent depressive disorder—currently in remission); a persistent mood (affective) disorder (e.g., cyclothymia or dysthymia); mixed affective episode; and recurrent brief depressive episodes.
- In some embodiments, the mental illness or behavioral disorder is a neurotic, stress-related, or somatoform disorder. Non-limiting examples of neurotic, stress-related, or somatoform disorders that affect the central nervous system include: a phobic anxiety disorder (e.g., agoraphobia, anthropophobia, social neurosis, acrophobia, animal phobias, claustrophobia, or simple phobia); an otherwise categorized anxiety disorder (e.g., panic disorder (episodic paroxysmal anxiety) or generalized anxiety disorder); obsessive-compulsive disorder; an adjustment disorder (e.g., acute stress reaction; post-traumatic stress disorder, or adjustment disorder); a dissociative (conversion) disorder (e.g., dissociative amnesia, dissociative fugue, dissociative stupor; trance disorder, possession disorder, dissociative motor disorder, dissociative convulsions, dissociative anaesthesia and sensory loss, mixed dissociative (conversion) disorder, Ganser's syndrome, or multiple personality disorder); a somatoform disorder (e.g., Briquet's disorder, multiple psychosomatic disorder, a hypochondriacal disorder—such as body dysmorphic disorder, dysmorphophobia (nondelusional), hypochondriacal neurosis, hypochondriasis, and nosophobia—a somatoform autonomic dysfunction—such as cardiac neurosis, Da Costa's syndrome, gastric neurosis, and neurocirculatory asthenia—or psychalgia); neurasthenia; depersonalization-derealization syndrome; Dhat syndrome, occupational neurosis (e.g., writer's cramp); psychasthenia; psychasthenic neurosis; and psychogenic syncope.
- In some embodiments, the mental illness or behavioral disorder is a behavioral syndrome associated with physiological disturbances or physical factors. Non-limiting examples of behavioral syndromes associated with physiological disturbances or physical factors that affect the central nervous system include: an eating disorder (e.g., anorexia nervos, atypical anorexia nervosa, bulimia nervosa, atypical bulimia nervosa, overeating associated with other psychological disturbances, vomiting associated with other psychological disturbances, or pica in adults); a nonorganic sleep disorder (e.g., nonorganic insomnia, nonorganic hypersomnia, nonorganic disorder of the sleep-wake schedule, sleepwalking (somnambulism), sleep terrors (night terrors), or nightmares); a sexual dysfunction not caused by organic disorder or disease; a mental or behavioral disorder associated with the puerperium (e.g., postnatal depression, postpartum depression, or puerperal psychosis); and abuse of non-dependence-producing substances.
- In some embodiments, the mental illness or behavioral disorder is an adult personality or behavior disorder. Non-limiting examples of adult personality and behavior disorders that affect the central nervous system include: a specific personality disorder (e.g., paranoid personality disorder, schizoid personality disorder, a dissocial personality disorder—such as antisocial personality disorder—an emotionally unstable personality disorder—such as borderline personality disorder—histrionic personality disorder, an anankastic personality disorder—such as obsessive-compulsive personality disorder, anxious (avoidant) personality disorder, dependent personality disorder, eccentric personality disorder, haltlose personality disorder, immature personality disorder, narcissistic personality disorder, passive-aggressive personality disorder, or psychoneurotic personality disorder); mixed personality disorder; a habit or impulse disorder (e.g., pathological gambling, pathological fire-setting (pyromania), pathological stealing (kleptomania), or trichotillomania); and Munchausen syndrome.
- In some embodiments, the mental illness or behavioral disorder is a psychological development disorder. Non-limiting examples of psychological development disorders that affect the central nervous system include: a developmental disorder of speech or language (e.g., specific speech articulation disorder, expressive language disorder, receptive language disorder (receptive aphasia), acquired aphasia with epilepsy (Landau-Kleffner disorder), or lisping); a developmental disorder of scholastic skills (e.g., a specific reading disorder—such as developmental dyslexia—specific spelling disorder, a specific disorder of arithmetical skills—such as developmental acalculia and Gerstmann syndrome—or a mixed disorder of scholastic skills); a developmental disorder of motor function (e.g., developmental dyspraxia); a mixed specific developmental disorder; and a pervasive developmental disorder (e.g., childhood autism, atypical autism, Rett's syndrome, overactive disorder associated with mental retardation and stereotyped movements, or Asperger's syndrome).
- In some embodiments, the mental illness or behavioral disorder is a behavioral or emotional disorder with onset usually occurring in childhood and adolescence. Non-limiting examples of behavioral or emotional disorders with onset usually occurring in childhood and adolescence that affect the central nervous system include: a hyperkinetic disorder (e.g., a disturbance of activity and attention—such as attention-deficit hyperactivity disorder and attention deficit syndrome with hyperactivity—or hyperkinetic conduct disorder); a conduct disorder (e.g., conduct disorder confined to the family context, unsocialized conduct disorder, socialized conduct disorder, or oppositional defiant disorder); a mixed disorder of conduct or emotions (e.g., depressive conduct disorder); an emotional disorder with onset specific to childhood (e.g., separation anxiety disorder of childhood, phobic anxiety disorder of childhood, social anxiety disorder of childhood, sibling rivalry disorder, identity disorder, or overanxious disorder); a disorder of social functioning with onset specific to childhood and adolescence (e.g., elective mutism, reactive attachment disorder of childhood, or disinhibited attachment disorder of childhood); a tic disorder (e.g., transient tic disorder, chronic motor or vocal tic disorder, or combined vocal and multiple motor tic disorder (de la Tourette)); and an otherwise classified behavioral or emotional disorder with onset usually occurring in childhood and adolescence (e.g., nonorganic enuresis, nonorganic encopresis, feeding disorder of infancy and childhood, pica of infancy and childhood, stereotyped movement disorders, stuttering (stammering), cluttering, attention deficit disorder without hyperactivity, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS), or Pediatric acute-onset neuropyschiatric syndrome (PANS)).
- In some embodiments, the at least one response prompts the system to present at least one additional question related to the at least one response. In related embodiments, the at least one response prompts the system to present at least one set of additional questions related to the at least one response. In some further embodiments, a set of additional questions comprises at least 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 questions.
- In other embodiments, the at least one response or responses of the subject to the at least one additional question or to the at least one set of additional questions prompts the system to present at least one additional question related to a different facet of the mental health of the subject. In related embodiments, the at least one response or responses of the subject to the at least one additional question or to the at least one set of additional questions prompts the system to present at least one set of additional questions related to a different facet of the mental health of the subject. In some further embodiments, a set of additional questions comprises at least 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 questions. In other related embodiments, the system present the subject with questions or sets of questions related to at least 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 facets of mental health.
- In some embodiments, the method comprises analyzing the at least one response by two health professionals. In some further embodiments, the at least one health professional is a mental health professional. In some still further embodiments, the mental health professional is a psychiatrist. In other further embodiments, the at least one health professional is a physician, who is in some embodiments the primary care physician of the subject. In some yet further embodiments, the two health professionals are a physician and a mental health professional.
- In some embodiments, the method further comprises the step of retrieving a medical history of the subject from a database and accepting the at least one attribute from the medical history for the determination of the mental state of the subject. In some embodiments, the method further comprises the step of presenting one or more questions about the medical history of the subject and receiving responses to the one or more questions about the medical history of the subject for the determination of the mental state or behavioral disorder of the subject.
- Attributes from the medical history include a list of previous illnesses, symptoms, medicines, treatments, health risk factors, operations, and/or doctor visits for the subject. In some embodiments, the medical history includes life history and/or social history characteristics such as smoking, drinking, drug use, sexual history, exercise history, eating history, nutraceutical history, or the like. In some embodiments, the medical history includes a family medical history. A family medical history may include a list of previous illnesses, symptoms, medicines, treatments, health risk factors, operations, and/or doctor visits associated with family members related to the subject.
- In some embodiments, the at least one attribute includes mental attributes of the subject. A mental attribute may include an attribute that may be related to and/or associated with basic mental function and/or high-level brain function. Some examples of a mental attribute may include an indication of learning disability, cognitive disability, measurements of brain activity, for example using functional MRI or near infra-red technology, and/or measurements of mental development.
- In some embodiments, the at least one attribute includes descriptions of mental symptoms of the subject. A mental symptom may include a manifestation, sign, and/or an indication of the presence of a disease and/or some other mental disorder and/or abnormality. Some examples of a mental symptom may include lack of attention, indication of stress, hyperactivity, nervousness, and/or lack of responsiveness.
- In some embodiments, the at least one attribute includes indication of anxiety, an appearance, a behavior, depression, fear, inattention, a mood disturbance, a phobia, or a psychological test result. Anxiety may include feelings of fear, apprehension, and/or worry and may be accompanied by physical sensations. An appearance may include an outward, audible, and/or visible aspect of a person and/or thing associated with a person. A behavior may include the manner in which a person and/or thing associated with a person acts and/or reacts. Depression may include a mental state characterized by pessimism, a sense of inadequacy, despondence, despair, a low level of energy, and/or a lack of activity. Fear may be caused by impending danger, perceived evil, and/or pain, whether real or imagined. Inattention may include the failure of a person to focus attention. A mood disturbance may include a change in emotional state. A phobia may include an irrational, and/or persistent fear of certain situations, objects, activities, and/or people. A psychological test result may include a sample behavior for inferring a certain generalization about a person. For example, a personality test result may indicate that person has obsessive/compulsive characteristics. In some instances, mental indication accepter module 636 may include a computer processor.
- In some embodiments, the at least one attribute includes at least one measurement associated with at least one of brain activity, cardiac activity, vascular activity, peripheral neural signals, hemodynamic activity, or metabolic activity. Brain activity may include the electrical activity of the brain, such as that measured by EEG, MEG, or the like. Other brain activity measurements may include functional MM imaging, near infra-red imaging, PET scanning, or the like. Cardiac activity may include electrical activity in the heart, such as that measured by EKG or visual imaging. Vascular activity may include any activity and/or function of the circulatory system. Peripheral neural signals may include neural signals sent through the peripheral nervous system. Hemodynamic activity may include any activity associated with the circulatory system. Metabolic activity may include any activity associated with the biochemical reactions occurring in a living organism. In some instances, mental activity accepter module 638 may include a computer processor.
- In some embodiments, the at least one attribute includes measurement of at least one brain activity surrogate marker. Brain activity surrogate markers may include indicators of attention, approval, disapproval, recognition, cognition, memory, trust, or the like in response to a stimulus, other than measurement of brain activity associated with the stimulus. Some examples of surrogate markers may include a skin response to a stimulus; a face pattern indicative of approval, disapproval, or emotional state; eye movements or pupil movements indicating visual attention to an object; voice stress patterns indicative of a mental state, or the like. Surrogate markers may be used in conjunction with brain activity measurements for higher confidence in a predictive or interpretational outcome. For example, brain activation of the caudate nucleus in combination with calm voice patterns may increase confidence in a predictor of trust between a subject and a stimulus. Additional discussion regarding surrogate markers may be found in Cohn, J. N., Introduction to Surrogate Markers, CIRCULATION 109: IV20-21, American Heart Association, (2004), which is incorporated herein by reference.
- In some embodiments, the at least one attribute includes measurement of iris dilation or constriction, gaze tracking, skin response, or voice response. In some embodiments, the medical history includes measurement of changes in the movement of an individual's iris (with corresponding changes in the size of the pupil) before, during, and/or after administration of a bioactive agent and/or an artificial sensory experience. Such measurements of physiologic activity that indicate brain activity and/or mental state may be carried out at a time that is proximate to administration of a bioactive agent and/or an artificial sensory experience.
- In some embodiments, the at least one attribute includes measurement of skin response of the subject. Brain activity may be determined by detection of a skin response associated with a stimulus. One skin response that may correlate with mental state and/or brain activity is galvanic skin response (GSR), also known as electrodermal response (EDR), psychogalvanic reflex (PGR), or skin conductance response (SCR). This is a change in the electrical resistance of the skin. There is a relationship between sympathetic nerve activity and emotional arousal, although one may not be able to identify the specific emotion being elicited. The GSR is highly sensitive to emotions in some people. Fear, anger, startle response, orienting response, and sexual feelings are all among the emotions which may produce similar GSR responses. GSR is typically measured using electrodes to measure skin electrical signals. For example, an Ultimate Game study measured skin-conductance responses as a surrogate marker or autonomic index for affective state, and found higher skin conductance activity for unfair offers, and as with insular activation in the brain, this measure discriminated between acceptances and rejections of these offers. See Sanfey, “Social Decision-Making: Insights from Game Theory and Neuroscience,” Science, vol. 318, pp. 598-601 (26 Oct. 2007), which is incorporated herein by reference. Other skin responses may include flushing, blushing, goose bumps, sweating, or the like.
- In some embodiments, the at least one attribute includes measurement of voice response. Voice response may include speech captured by a microphone during presentation of a characteristic. Speech or voice can be measured, for example, by examining voice, song, and/or other vocal utterances of a subject before, during, and/or after administration of a bioactive agent and/or an artificial sensory experience to an individual. Such measurements may include, for example, as discussed above, layered voice analysis, voice stress analysis, or the like.
- In some embodiments, the at least one attribute includes personal identification data, physical characteristics data, health profile data, family health history data, drug and vitamin/mineral supplement data, health baseline data, diet and nutritional data, environmental exposure data, and behavioral data.
- The personal identification data comprises essential personal information that facilitates the identification of an individual and the establishment of core demographic characteristics. For example, the personal identification data includes name, address, residence history, age, gender, race, ethnicity, education, sexual preference, martial status, living arrangements, marital history, children, occupation, work history, home and work environments, travel history, military service history, genealogy, relationships, recreational activities and the like. Sensitive information, such as name and street address, may be segregated and coded for privacy and security.
- The physical characteristics data includes height, weight, body fat ratio, body symmetry and dimensions, skin shade and texture, eye color, hair growth/color and texture, strength symmetry, endurance, coordination, posture, gait, nail growth and features, feet size, physical peculiarities, physical deformities, growths, blemishes, teeth and gums, flexibility, and the like. These characteristics are useful in establishing the subscriber's physical uniqueness as well as their membership in population groups that share certain characteristics.
- The health profile data comprises a broad array of information pertaining to the subscriber's psychological and physiological characteristics and condition, medical history data, hazardous and toxic material exposure data, allergies data, disabilities, reproductive history, depression data, family (genealogy) health history data stress level data, mental condition data, current health conditions data, physical sensitivities and pain data, activity level and physical fitness data, illnesses history data, history of injuries data, chronic conditions data, visual acuity data, night vision data, hearing acuity data, reaction time data and the like. The health profile data also incorporates the results of quantitative tests including blood chemistry tests, breath analysis (i.e., laser absorption spectroscopy), medical imaging (i.e., x-rays, magnetic resonance imaging, lithotripsy, computed tomography, fluorescence spectroscopy, ultrasounds, thermographs, and others), photographic imaging, and other psychological, physical, and physiological tests.
- The family health history addresses the health conditions and unique characteristics of the subject's living and deceased blood relatives. The family health history data is comprised of personal description data, physical description data, physical characteristics, demographic data, occupational data, disabilities, behaviors, health and medical histories, and the like. The family history data collection includes names, birthdates, place of birth, number of children (including genders and birthdates), places of residency, health histories, ages at death, height, weight, physical and health peculiarities, chronic conditions, sensitivities/allergies, disease history, cause of death, health conditions at time of death, history of injuries, deformities, visual acuity, hearing acuity, mental condition and acuity, disabilities, occupations/professions, medication history (including diagnosis, treatments, test results, evaluations, and the like), reproductive histories, alcohol and drug usage, blood types, and other psychological, physical, physiological and behavioral details that would be useful in the identification of genetic characteristics and predispositions.
- The drug and vitamin/mineral supplement data comprises a detailed history of prescription and non-prescription drugs, vitamin supplements, herbs, and mineral supplement usages. Included in the history may be the item description, dosage, frequency taken, date started, reason for taking, date stopped, reason for stopping, and observed effects, side effects, reactions, and the like.
- The health baseline data may, in part, be derived from information compiled in previous databases including, the personal identification data, physical characteristics data and health profile data. Certain key psychological characteristics (i.e., depression, confusion, neurosis and other like mental conditions or mental cognitive peculiarities), physical characteristics (i.e., height, weight, body fat ratio, posture, flexibility, mobility, hair growth, hair color, skin color/tone, eye color and the like), physiological characteristics (i.e., visual performance, hearing performance, blood pressure, heart rate, repertory rate, heart rhythm, blood chemistry, and other major organ system performance characteristics), and medical conditions may be recorded and updated over a period of time. The resulting database will depict each characteristic separately and their respective performance values.
- In some cases, the data may be subject to a patterns-analysis, which identifies repetitive fluctuations in order to establish predictable patterns, ranges of fluctuation and rate of change. Where possible, certain pattern fluctuations are linked to predictable cycles, such as, time-of-day, seasons, and biological cycles. In addition, the subscriber's physical, psychological, physiological and behavioral characteristics (including patterns) may be assessed relative to authoritative standards and norms of similar population groups. The resulting compilation of data forms a baseline or reference-point to which new data, representing the latest health condition of the subscriber for comparison. The comparison provides a basis for determining whether the new data is consistent with or deviates from the baseline. The deviations may be positive (improvements in a condition), negative (evidence of deterioration), or they may be evidence of a new condition or abnormality.
- The diet and nutritional data (also referred to as diet and nutritional profile) systematically records the subscriber's dietary and nutritional intake and eating practices over time. For example, data may be obtained by periodically requesting information on what, how much, and when the subscriber ate and/or drank. The requests for information may target the time period of about 2 to about 8 hours preceding the request and the requests may be systematically timed so that every conscious hour may be eventually subjected to multiple requests for information. Next, the subscriber's food intake (including drinks and snacks) may be subjected to a comprehensive nutritional evaluation which establishes the nutritional value of the ingested substances including the amount and type of vitamins, minerals, calories, protein, carbohydrates, antioxidants, sodium, fats and the like. Each meal and snack (including drinks) is assessed and registered in order to construct a detailed, chronological image of the subscriber's dietary intake. This data may be subjected to pattern-analysis in order to identify repetitive patterns and associate fluctuations within the patterns to their influencing factors. The resulting diet and nutritional profile may be continuously updated in order to represent the subscriber's most current dietary intake. As an additional feature, specific food and drink descriptions and quantities consumed are documented and used to identify dietary preferences and predispositions.
- The environmental exposure data consists of those environmental characteristics that describe both natural environmental considerations (i.e., natural occurrences such as outside air temperature, humidity, sunlight, naturally occurring toxic/hazardous emissions, terrain, rain, water temperature, and others), manmade or man influenced environments considerations (i.e., air conditioning, heating, ergonomics, lighting, pollution and contamination, traffic, and the like), and hazardous environments (i.e., intentional and unintentional manmade or man caused environmental considerations such as exposure to dangerous situations and dangerous substances such as nuclear materials, toxic or hazardous biological substances, and toxic or hazardous chemicals, and the like).
- The behavior data (also referred to as behavior profile) documents a variety of behaviors that are known to affect wellness and longevity. To simplify behavior assessment, and, as used herein, “behaviors” are strictly defined as the actions taken by a person to relax, deal with stress, and occupy free time. The behaviors, amount of time spent in these behaviors, and the degree or intensity in which the subscriber participates in a behavior may be registered. The behaviors may be divided into three general categories. The first category includes behaviors that involve taking a substance (alcohol, tobacco, drugs, food, coffee, and the like). The second category includes behaviors that require doing something (jogging, watching sports, gambling, watching TV, playing golf, conversations, sewing, and the like). The third category addresses coping impulses which include impulsive reactions to anger, affection, fear, confusion, and embarrassment. The data acquired may be subjected to a pattern-analysis to identify repetitive patterns and tendencies.
- Psychological characteristics address the subscriber's mental state and processes including emotions and behaviors. The physiological characteristics data address the normal and abnormal performance characteristics of the subscriber's organ systems. These may include data such as vital signs, cardiovascular system, respiratory system, nervous system, skin system, musculoskeletal system, blood system, digestive system, endocrine system, urinary system, reproductive system and combinations comprising at least one of the foregoing for establishing unique characteristics and performance that may include visual acuity, blood pressure, heart rate and rhythm, respiratory rate, blood oxygen level, cholesterol levels, estrogen level, hearing acuity and sensitivity, sensory perception, PSA level, insulin levels, mental clarity, responsiveness, gait, posture, balance, teeth and gum condition, skin abnormalities, inflammation, pain, discomfort, discharges and the like.
- The medical history of the subject or the response the subject gives to in response to the one or more questions about the subject's medical history may be used in the determination of the subject's mental status by virtue of the symptoms or symptoms groups displayed by subjects. Without limiting the scope of the present disclosure, exemplary symptoms are somatic concern, anxiety, depressed mood, suicidality, guilt, hostility, aggression, elated mood, grandiosity, pressure of speech, suspiciousness/persecution, auditory or visual hallucinations, ideas of reference or control, unusual or bizarre thought content, thought disorder, bizarre behavior, self-neglect, self-harm, threats to others, disorientation, conceptual disorganization, blunted or flat affect, emotional withdrawal, apathy, social withdrawal, social anxiety, motor retardation, tension, uncooperativeness, excitement, inattention, distractibility, motor hyperactivity, mannerisms or posturing, movement disorder, delusions, poor rapport, passivity, poor abstract thinking, reduced or absent theory of mind, reduced insight, reduced judgment, reduced memory, anti-social traits, tendencies or acts, chronic regional pain or other unexplained chronic pain syndrome, offending behavior of a forensic nature, disturbance of volition, poor impulse control, anger, delayed gratification difficulty, affective lability, mood lability, mood swings, active social avoidance, preoccupation, obsessional preoccupation, ruminations, disturbance of spontaneity or flow of conversation, poor self care, anxious worrying, tension, tonicity, grasp strength, rumination, fear, active/intentional and passive/unintentional avoidance, dissociation, stress, attenuated psychotic symptoms, overvalued ideation, brief intermittent psychotic symptoms, subjective self-disturbance, re-experiencing phenomena, sense of presence, distancing, corporeality, disturbed stream of consciousness, self-other boundary disturbances, self-demarcation disturbances, body image disturbances, anorexia, orientation and re-orientation disturbances, self-consciousness, first rank passivity symptoms, ideas of reference or control, loss of sense of self, thought insertion, thought broadcasting, thought blocking, thought replacement, abnormal perception, delusional attribution or interpretation, under-arousal, disinhibition, impulsivity, over-aropusal, difficulty attending, reduced attention span, scattered attention, distressing recollections, emotional dysregulation, implausible belief, obsessional compensations, intrusive auditory thoughts, euphoria, apathy, and irritability.
- In some embodiments, the at least one attribute includes characteristics of certain receptors, such as serotonin receptors, dopamine receptors, estrogen receptors and adrenergic receptors in the subject. In some embodiments, at least one attribute includes the one or more events, such as stroke, hypertension, diabetes, cardiovascular diseases, kidney disorders can cancer, in the subject's medical history.
- In some embodiments, the method of determining the mental state of a subject comprises determining the mental competency to perform a function. In certain embodiments, the function concerns the capacity to operate a firearm. In other embodiments, the function comprises operating a motor vehicle. In some embodiments, the motor vehicle is an automobile. In other embodiments, the motor vehicle is an aircraft, boat or ship.
- In some embodiments, the method comprises determining the mental state of a subject in order to determine whether the subject can purchase and/or possess a firearm, whether the subject possesses the mental capacity to safely operate a firearm, whether the subject has the mental capacity to safely own or operate a motor vehicle, or whether the subject's responses are contrary to other information previously supplied to other health professionals, law enforcement professionals, probation officials, immigration authorities or other governmental agencies.
- In some embodiments, the mental state of the subject is determined based on the assessment score. In further embodiments, a depression severity questionnaire is presented to the subject when the score indicates the presence of depression in the subject. In other embodiments, the method further comprises collecting demographic information regarding the subject. This information may be used in the calculation of one or more of the assessment scores.
- The system may further include an alert database, which includes information concerning a number of mental states or behavioral disorders that can pose a danger to the subject, the subject's family, other people, as well as property. In certain cases, the alert may be related to a health danger such as, but not limited to, heart attack, stroke, aneurism, or dementia. In other cases, the alert is related to the capacity to own or operate firearms or motor vehicles. In other cases, the alert may relate to information contrary to information previously supplied by the subject to government authorities or agencies.
- In some embodiments, the alert database includes a matrix for converting one or more responses to one or more questions in the assessment to generate one of more assessment scores for determining if the system should additionally send an automatic alert to one or more additional health professionals, law enforcement professionals, probation officials, motor vehicle licensing professionals, immigration officials, or a combination thereof. Each of assessment scores may be compared with a threshold score for activating the alert, wherein a score exceeding the threshold triggers activation of the alert. In some embodiments, the alert is categorized into multiple levels e.g., level 1, level 2 and level 3 alert with level 3 alert being the most serious alert level. In some embodiments, the alert level is color-coded, e.g., level blue, level orange and level red alert with level red alert being the most serious alert level. In some embodiments, the alert is presented in the form of an alert signal on the computer screen for the health professionals' review. In other embodiments, the alert level is listed as an item of an assessment report generated by the system for review by the health professionals.
- In some embodiments, the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history triggers the system to present an automatic alert for review by the at least one health professional if the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history matches an alert event in the alert database.
- Pursuant to the review by the health professional and an analysis of other alert events in the alert database, the system may further send an automatic alert to additional health professionals, law enforcement professionals, probation officials, motor vehicle licensing professionals, immigration authorities, or a combination thereof.
- In yet other embodiments, there are a plurality of assessments; and the plurality of assessments are administered preferentially. In some embodiments, the term “administered preferentially” means that a subsequent assessment is administered to the subject based upon an answer to a preceding assessment.
- In even other embodiments, the system is configured on a handheld device. In some embodiments the handheld device is a laptop computer, tablet computer, smartphone, or PDA.
- In some embodiments, the method further comprises determining if the subject is undergoing an initial wellness assessment or a follow-up.
- The determined mental state can include any of the above-described disorders. In certain embodiments, the determined mental state is a behavioral disorder selected from the group consisting of depression, substance abuse, risk for bipolar disorder, and post-traumatic stress disorder.
- Another aspect of the present application relates to a system for assessment of a mental state of a subject. The system includes: a computer-readable memory, the computer-readable memory configured to store computer-executable instructions; an input device configured to receive an input from the subject; and a processor configured to execute the computer-executable instructions. The computer-executable instructions include prompting the subject with at least one question in a system for assessment of mental state on a display; recording at least one response to the at least one assessment, wherein the at least one response comprises a long-form answer; converting the at least one response into at least one assessment score; generating an output comprising the at least one assessment score for assessment of the mental state of the subject by at least one health professional; retrieving a medical history of the subject from a database and accepting at least one attribute from the medical history for the determination of the mental state of the subject, and/or presenting one or more questions about the medical history of the subject and receiving at least one response to the one or more questions about the medical history of the subject for the determination of the mental state of the subject, wherein the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history triggers the system to present an automatic alert for review by the at least one health professional if the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history matches an alert event in an alert database; and generating a report of the mental state of the subject based on the assessment by the at least one health professional and incorporating the report into an electronic health record associated with the subject.
- In some embodiments, the computer-executable instructions further comprise: a plurality of assessments; and the plurality of assessments is administered preferentially.
- In some embodiments, the system is configured on a handheld device.
- In other embodiments, the computer-executable instructions further comprise determining if the subject is undergoing an initial wellness assessment or a follow-up.
- In yet other embodiments, the computer-executable instructions further comprise collecting demographic information regarding the subject.
- In certain embodiments, the diagnosed behavior disorder includes, or is caused by, a mental disorder or a behavioral disorder as described herein. In particular embodiments, the diagnosed behavioral disorders include at least one of depression, substance abuse, risk for bipolar disorder, and post-traumatic stress disorder.
-
FIG. 1 is a block diagram illustrating exemplary hardware components that may be used for implementing aspects of the system and method for using a wellness assessmentbehavioral health kiosk 10. Acomputer system 100 may include and execute programs to perform functions described herein, including steps of method described above. While only oneprocessor 114 is shown inFIG. 1 , it is understood that thecomputer system 100 used to implement the wellness assessmentbehavioral health kiosk 10 may include multiple processors. Additionally, a system for implementing the wellness assessmentbehavioral health kiosk 10 may include multiplenetworked computer systems 100. Further, a mobile device that includes some of the same components ofcomputer system 100 may perform steps of the method described above.Computer system 100 may connect with anetwork 118, e.g., Internet, or other network, to receive inquires, obtain data, and transmit information (e.g., to a user work station or other user computing device) as described above. -
Computer system 100 typically includes amemory 102, asecondary storage device 112, and aprocessor 114.Computer system 100 may also include a plurality ofprocessors 114 and be configured as a plurality of, e.g., bladed servers, or other known server configurations.Computer system 100 may also include aninput device 116, adisplay device 110, and anoutput device 108. -
Memory 102 may include RAM or similar types of memory, and it may store one or more applications for execution byprocessor 114.Secondary storage device 112 may include a hard disk drive, floppy disk drive, CD-ROM drive, or other types of non-volatile data storage.Processor 114 may include multiple processors or include one or more multi-core processors. Any type ofprocessor 114 capable of performing the calculations described herein may be used.Processor 114 may execute the application(s) that are stored inmemory 102 orsecondary storage 112, or received from the Internet orother network 118. The processing byprocessor 114 may be implemented in software, such as software modules, for execution by computers or other machines. These applications preferably include instructions executable to perform the functions and methods described above and illustrated in the Figures herein. The applications may provide graphic user interfaces (GUIs) through which users may view and interact with the application(s). - Also, as noted,
processor 114 may execute one or more software applications in order to provide the functions described in this specification, specifically to execute and perform the steps and functions in the methods described above. Such methods and the processing may be implemented in software, such as software modules, for execution by computers or other machines. -
Input device 116 may include any device for entering information intocomputer system 100, such as a touch-screen, keyboard, mouse, cursor-control device, microphone, digital camera, video recorder or camcorder.Input device 116 may be used to enter information into GUIs during performance of the methods described above.Display device 110 may include any type of device for presenting visual information such as, for example, a computer monitor or flat-screen display (or mobile device screen).Output device 108 may include any type of device for presenting a hard copy of information, such as a printer, and other types of output devices include speakers or any device for providing information in audio form. - Examples of
computer system 100 include dedicated server computers, such as bladed servers, personal computers, laptop computers, notebook computers, palm top computers, network computers, mobile devices, or any processor-controlled device capable of executing a web browser or other type of application for interacting with the system. Ifcomputer system 100 is a server,server 100 may not includeinput device 116,display device 110 andoutput device 108. Rather,server 100 may be connected, e.g., through a network connection to a stand-alone work station (another computer system) that has such devices. - Although only one
computer system 100 is shown in detail, the system for using a wellness assessmentbehavioral health kiosk 10 may use multiple computer systems or servers as necessary or desired to support the users, as described above. Aspects may also use back-up or redundant servers to prevent network downtime in the event of a failure of a particular server. In addition, althoughcomputer system 100 is depicted with various components, one skilled in the art will appreciate that the server can contain additional or different components. In addition, although aspects of an implementation consistent with the above are described as being stored in memory, one skilled in the art will appreciate that these aspects can also be stored on or read from other types of computer program products or computer-readable media, such as secondary storage devices, including hard disks, floppy disks, or CD-ROM; or other forms of RAM or ROM. Computer-readable media may include instructions for controlling a computer system, such as thecomputer system 100, to perform a particular method, such as methods described above. -
FIGS. 2A and 2B show amethod 200 of using the wellness assessmentbehavioral health kiosk 10, according to one aspect of this disclosure. Themethod 200 may begin by providing a welcome screen atblock 202 to a user of the wellness assessmentbehavioral health kiosk 10. At the welcome screen, the wellness assessmentbehavioral health kiosk 10 may prompt the user to select from, for example, two options. One option may be that the user is conducting her first wellness assessment and therefore, the user completes the full wellness assessment. Alternatively, the user may have already previously conducted a wellness assessment and is at the facility to conduct a follow-up visit. Atblock 204, themethod 200 may determine which option the user has selected. If the user selects the option of a follow-up visit, themethod 200 may proceed to block 206. If the user selects conducting an entire wellness assessment, themethod 200 may proceed to block 210. - At
block 206, the method may prompt the user to complete a follow-up assessment. The follow-up assessment may ask the user a variety of questions related to the user. For example, the follow-up assessment may ask the user questions about the user's progress. These questions may be tailored to the previous wellness assessment the user may have taken. For example, if the user had previously talked to her healthcare professional about an alcohol abuse problem, themethod 200 may ask the user follow-up questions related to alcohol abuse. For example, themethod 200 may ask the user if the user has decreased the amount of alcohol the user consumes per week or if she has sought additional help, for example, attending Alcoholics Anonymous meetings. These questions may be set without customization to the user. Alternatively, the questions may be tailored to the user based on, for example, notes previously made entered into the wellness kiosk by the user's healthcare professional. Once the user completes the follow-up questionnaire, themethod 200 may proceed to block 208. - At
block 208, themethod 200 may output the results of the follow-up questionnaire completed inblock 206. For example, themethod 200 may print the questions and answers of the follow-up questionnaire. Alternatively, or additionally, themethod 200 may output the results of the follow-up questionnaire electronically. For example, themethod 200 may output the results as an email to the user's healthcare professional. Alternatively, or additionally, themethod 200 may output the results to the user's electronic health records. For example, the results may be incorporated into the user's preexisting electronic health records. If the user does not have a preexisting electronic health record, then the method may generate a new electronic health record for the user. - If, at
block 204, the user selected to start a new wellness assessment, themethod 200 may continue to block 210. Atblock 210, the wellness assessmentbehavioral health kiosk 10 may prompt the user to enter demographic information. The demographic information may include, for example, the user's age, weight, height, ethnicity, gender, education, household composition, employment status, and other factors that may be useful in diagnosing the user. One of ordinary skill in the art would readily recognize that many other demographic aspects may be useful in diagnosing the user. Once the user has entered the demographic information, themethod 200 may proceed to block 212. - At
block 212, the wellness assessmentbehavioral health kiosk 10 may prompt the user to answer a series of behavioral questions. For example, the wellness assessmentbehavioral health kiosk 10 may ask the user to complete a series of questions related to the frequency of depressed mood and anhedonia over a period of time. For example, one common questionnaire used in diagnosing mental health conditions is the Patient Health Questionnaire-2 (PHQ-2). The PHQ-2 is used generally to screen for depressive behavior rather than a final diagnosis. Using the PHQ-2, the wellness assessmentbehavioral health kiosk 10 may ask the user about the user's frequency of depressed mood and anhedonia over the past two weeks. Based on the answers to the questions presented by the PHQ-2, the wellness assessmentbehavioral health kiosk 10 may assign a score to the user. In one aspect of this disclosure, the higher the score the wellness assessmentbehavioral health kiosk 10 assigns to the user's responses, the more likely that the user may be depressed. When the user has completed the behavioral health questions inblock 212, themethod 200 may proceed to block 214. - At
block 214, the wellness assessmentbehavioral health kiosk 10 may analyze the score generated inblock 212. For example, the wellness assessmentbehavioral health kiosk 10 may have a minimum threshold for screening for depression. For example, the wellness assessmentbehavioral health kiosk 10 may determine that the user may have depression if the score is equal to or higher than two. One of ordinary skill in the art would readily recognize that any threshold may be used. For example, the lower the threshold, the more sensitive the wellness assessmentbehavioral health kiosk 10 may be to detecting depressive behavior. Conversely, the higher the threshold, the less sensitive the wellness assessmentbehavioral health kiosk 10 may be to detecting depressive behavior. If the threshold inblock 214 has not been met, then themethod 200 may proceed to block 216. If the threshold inblock 214 has been met, then themethod 200 may proceed to block 222. - At
block 216, the wellness assessmentbehavioral health kiosk 10 may ask the user to complete a post-traumatic stress disorder (PTSD) questionnaire. For example, the wellness assessmentbehavioral health kiosk 10 may ask the user questions from the primary care PTSD (PC-PTSD) screen. For example, the PC-PTSD screen may include an introductory sentence or paragraph to cue respondents to traumatic events. The PC-PTSD screen may then ask a series of questions to the user to detect PTSD. Based on the answers to the questions, the wellness assessmentbehavioral health kiosk 10 may generate a score. Once the user has completed the PTSD questionnaire inblock 216, themethod 200 may proceed to block 218. - At
block 218, the wellness assessmentbehavioral health kiosk 10 may analyze the generated PTSD questionnaire score to determine the likelihood that the user suffers from PTSD. For example, the wellness assessmentbehavioral health kiosk 10 may have a minimum threshold for screening for PTSD. For example, the wellness assessmentbehavioral health kiosk 10 may determine that the user may have PTSD if the score is equal to or higher than three. One of ordinary skill in the art would readily recognize that any threshold may be used. For example, the lower the threshold, the more sensitive the wellness assessmentbehavioral health kiosk 10 may be to detecting PTSD. Conversely, the higher the threshold, the less sensitive the wellness assessmentbehavioral health kiosk 10 may be to detecting PTSD. If the threshold inblock 218 has not been met, then themethod 200 may proceed to block 224. If the threshold inblock 218 has been met, then themethod 200 may proceed to block 220. - At
block 220, the wellness assessmentbehavioral health kiosk 10 may ask the user to complete a second PTSD questionnaire. This second PTSD questionnaire may ask questions in more depth than the PTSD questionnaire inblock 216. For example, the wellness assessmentbehavioral health kiosk 10 may ask questions that are found in the PTSD CheckList—Civilian Version. The wellness assessmentbehavioral health kiosk 10 may generate a score based on the answers the user provided to the questions. Once the user has completed the second PTSD questionnaire, themethod 200 may proceed to block 224. - If the user did meet the threshold in
block 214, themethod 200 may proceed to block 222. Atblock 222, the wellness assessmentbehavioral health kiosk 10 may ask the user to complete a more in-depth depression severity questionnaire. For example, the wellness assessmentbehavioral health kiosk 10 may ask the user to complete a Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 may be used to screen, diagnose, monitor, and measure a severity of depression. The more in-depth depression severity questionnaire ofblock 222 may be a continuation of the questionnaire presented inblock 212. Based on the answers provided by the user, the wellness assessmentbehavioral health kiosk 10 may generate a score that represents, for example, whether the user exhibits depressive behavior and the severity of any depressive behavior. Afterblock 222 is complete, themethod 200 may proceed to block 224. - At
block 224, the wellness assessmentbehavioral health kiosk 10 may ask the user to complete a bipolar risk factor questionnaire. For example, the wellness assessmentbehavioral health kiosk 10 may ask the user if the user had ever been diagnosed with bipolar disorder or had ever experienced a manic episode. Additionally, or alternatively, the wellness assessmentbehavioral health kiosk 10 may ask the user about the user's family history. For example, the wellness assessmentbehavioral health kiosk 10 may ask if any of the user's parents, siblings, or other ancestors had suffered from bipolar disorder or had ever experienced a manic episode. Additionally, or alternatively, the wellness assessmentbehavioral health kiosk 10 may ask the user for additional details regarding the subject's depression. For example, the wellness assessmentbehavioral health kiosk 10 may prompt the user for information, such as how suddenly the depression symptoms manifested. Additionally, or alternatively, the wellness assessmentbehavioral health kiosk 10 may ask the user when the first depressive episode occurred. For example, the wellness assessment behavioral health kiosk may ask the user if the first depressive episode occurred before a certain age, such as eighteen years old. Once the user has answered these questions, the wellness assessmentbehavioral health kiosk 10 may generate a score based on the answers provided by the user. Afterblock 224 is complete, themethod 200 may proceed to block 226. - At
block 226, the wellness assessmentbehavioral health kiosk 10 may determine, based on the score generated inblock 224, whether the user should be further screened for a mood disorder. For example, the wellness assessmentbehavioral health kiosk 10 may have a minimum threshold for screening for bipolar disorder risk. For example, the wellness assessmentbehavioral health kiosk 10 may determine that the user may have bipolar disorder if the score is equal to or higher than one. One of ordinary skill in the art would readily recognize that any threshold may be used. For example, the lower the threshold, the more sensitive the wellness assessmentbehavioral health kiosk 10 may be to detecting bipolar disorder. Conversely, the higher the threshold, the less sensitive the wellness assessmentbehavioral health kiosk 10 may be to detecting bipolar disorder. If the threshold inblock 226 has not been met, then themethod 200 may proceed to block 230. If the threshold inblock 226 has been met, then themethod 200 may proceed to block 228. - At
block 228, the wellness assessmentbehavioral kiosk 100 may ask the user additional questions related to the user's mood. After the user has answered the questions, the wellness assessmentbehavioral kiosk 100 may generate a score based on the answers. When block 228 is finished, themethod 200 may proceed to block 230. - At
block 230, the wellness assessmentbehavioral kiosk 100 may ask the user pre-screening questions related to alcohol, drug, and tobacco use. For example, the wellness assessmentbehavioral kiosk 100 may use the Screening, Brief Intervention, and Referral to Treatment (SBIRT) pre-screening questions. For example, the SBIRT pre-screen may ask when the user last had a certain amount of drinks in a given period of time, such as four drinks in one day. Additionally, or alternatively, the SBIRT pre-screen may ask the user if the user has used drugs within a period of time, such as within the last twelve months. Additionally, or alternatively, the SBIRT pre-screen may ask the user if the user uses tobacco in any form. Once the user has answered these questions, the wellness assessmentbehavioral kiosk 100 may store the answers. The stored answers may be used later in themethod 200, as described below. Onceblock 230 is complete, the method proceeds along path A, which continues on toFIG. 2B . Path A may branch into three different directions. For example, path A may continue to block 232. - At
block 232, the wellness assessmentbehavioral kiosk 100 may determine if the user has answered positively to alcohol. In other words, block 232 may determine if the user has used alcohol as described above with reference to block 230. If the user is not positive for alcohol, then themethod 200 may proceed to block 238. However, if the user is positive for alcohol, then themethod 200 may proceed to block 234. - At
block 234, the wellness assessmentbehavioral kiosk 100 may ask the user to complete an alcohol use disorders questionnaire. For example, the alcohol use disorders questionnaire may be the Alcohol Use Disorders Identification Test (AUDIT). In one aspect, the wellness assessmentbehavioral kiosk 100 may use AUDIT to ask the user ten questions to gauge the user's alcohol consumption, drinking behaviors, and alcohol-related problems. Such questions may include questions regarding the frequency of alcohol use, the type of alcohol used, and whether the alcohol use has impaired the user's ability to function in day to day life. The wellness assessment behavioral kiosk may generate a score based on the answers the user provided in response to the alcohol use disorders questionnaire. Once the user has finished answering the questionnaire, themethod 200 may proceed in two parallel paths. For example, in one of the parallel paths, themethod 200 may proceed to block 238. In the other parallel path, themethod 200 may proceed to block 236, which is analyzed in the context of both alcohol and drugs. - At
block 238, the wellness assessmentbehavioral health kiosk 10 may ask the user to complete a set of resilience questions. Once the user has answered the resilience questions, themethod 200 may proceed to block 240. - At
block 240, the wellness assessmentbehavioral health kiosk 10 may output the results of the wellness assessment. For example, themethod 200 may print the questions and answers of the assessment. Alternatively, or additionally, themethod 200 may output the results of the assessment electronically. For example, themethod 200 may output the results as an email to the user's healthcare professional. Alternatively, or additionally, themethod 200 may output the results to the user's electronic health records. For example, the results may be incorporated into the user's preexisting electronic health records. If the user does not have a preexisting electronic health record, then the method may generate a new electronic health record for the user. Themethod 200 may then end. - Another parallel path the
method 200 may have taken afterblock 230 isblock 242, which determines if the user has answered positively for drugs. If the user has answered positively for drugs, themethod 200 may proceed to block 244. - At
block 244, the wellness assessmentbehavioral kiosk 100 may ask the user to complete a drug abuse screening questionnaire. In one aspect, the drug abuse screening questionnaire may be the Drug Abuse Screening Test (DAST). The DAST may ask, for example, ten questions about the user's drug use in the past twelve months. The DAST asks only about drug use, not alcohol or tobacco. One of ordinary skill in the art would readily recognize that tests other than DAST may be used and that these other tests may ask questions about other behavior, including alcohol and tobacco use. For example, the wellness assessment behavioral health kiosk may ask the user for what types of drugs the user uses, the frequency of use for each type of drug, the form in which the user uses the drug, and other questions designed to explore the user's drug use behavior. Once the user has completed the drug abuse screening questionnaire, themethod 200 may proceed to block 246. - At
block 246, the wellness assessmentbehavioral kiosk 100 may determine if the user has answered positively for both alcohol and drug use. If the user has answered positively for both alcohol and drug use, themethod 200 may proceed to block 234, as described above. However, if the user has not answered positively for both drugs and alcohol, themethod 200 may proceed to block 248. - At
block 248, the wellness assessmentbehavioral kiosk 100 may ask the user to complete a set of resilience questions. These resilience questions may be the same as or similar to the resilience questions asked inblock 238, as described above. Once the user has completedblock 248, themethod 200 may proceed to block 250. - At
block 250, the wellness assessmentbehavioral kiosk 100 may output the results of the wellness assessment.Block 250 is similar to block 240, as described above. - If the user did not answer positively for drugs at
block 242, themethod 200 may proceed directly to block 248 and then to block 250, as described above. - Another
parallel path method 200 may take afterblock 230 isblock 252, which determines if the user has answered positively for tobacco use. If the user has indicated that the user uses tobacco, then themethod 200 may proceed to block 254. - At
block 254, themethod 200 may ask the user if the user is interested in quitting tobacco use. Once the user completes thisblock 254, themethod 200 may proceed to block 256. - At
block 256, the wellness assessmentbehavioral kiosk 100 may ask the user a series of resilience questions. These questions may be identical or similar to the resilience questions asked in 238 and 248. Onceblocks block 256 is completed, themethod 200 may proceed to block 258. - At block 258, the wellness assessment
behavioral kiosk 100 may output the results of the wellness assessment. The wellness assessmentbehavioral kiosk 100 may output the results as described above in, for example, blocks 240 and 250. However, if the user was not positive for tobacco atblock 252, then themethod 200 may proceed directly toblocks 256 and then 258, as described above. Themethod 200 may then end. - At each block of the
method 200, the wellness assessmentbehavioral kiosk 100 may allow the user to input additional information. For example, for a given questionnaire, the questionnaire may allow the user to input sentences, short answers, or paragraphs to elaborate on the answers already given. In this way, the user is able to provide a more comprehensive answer that may provide nuance lost in the questionnaire. - Additionally, in another aspect of this disclosure, healthcare professionals may be able to specify certain important words or phrases in any of the longer responses provided by the user. For example, if the user provides, in a long for answer, that the user is contemplating suicide by using the word suicide, the wellness assessment
behavioral kiosk 100 may be configured to highlight the word suicide in the outputted results. These important words or phrases may be generally applicable to all users of the wellness assessmentbehavioral kiosk 100. Additionally, or alternately, the important words or phrases may be tailored for each user, based on previously provided answers or course of treatment. In this way, the healthcare professional may be quickly alerted to areas of particular concern. - Moreover, as described in the description of the
method 200, various blocks may generate a score based on the responses given by the user. Themethod 200 may then compare the generated score to various score thresholds. In one aspect of this disclosure, a score threshold may be pre-defined and unchangeable. In another aspect of this disclosure, the score threshold may be configurable by, for example, a healthcare professional. Moreover, in another aspect of this disclosure, the score threshold may be tailored for each user. For example, if a user has shown in the past to be more vulnerable to alcohol abuse, the score threshold may be lower for this user to attempt to prevent the alcohol abuse from becoming worse. Moreover, in another aspect, the score threshold may be dependent on demographic information. For example, if a user indicates that the user is divorced, the score threshold for that user for depressive behavior may be reduced. -
FIG. 3 shows anotherexemplary method 300 of using the wellness assessmentbehavioral health kiosk 10. Themethod 300 may begin atblock 302. Atblock 302, the wellness assessmentbehavioral health kiosk 10 may receive input from a user in response to a mental competency assessment. For example, the wellness assessmentbehavioral health kiosk 10 may receive input from the user in response to various assessments, such as the assessments described above, for example, in 204, 206, 210, 212, 216, 220, 222, 224, 228, 230, 234, 238, 244, 248, 252, and 254 inblocks method 200. Afterblock 302 is complete, themethod 300 may proceed to block 304. - At
block 304, the wellness assessmentbehavioral health kiosk 10 may transmit the user input gathered inblock 302 to a healthcare professional. WhileFIG. 3 shows that block 304 followsblock 302, one of ordinary skill in the art would readily recognize that the wellness assessmentbehavioral health kiosk 10 may transmit the inputted information as the user inputs the information or it may transmit the inputted information once all of the information has been gathered. The user input may be transmitted to another device, such as a computer located near a healthcare professional. One of ordinary skill in the art would readily recognize that any device capable of receiving such information may receive the transmitted information. The user input may be transmitted over a network, such asnetwork 118. The healthcare professional may be, for example, a primary physician. There may also be more than one healthcare professional. For example, the information may be transmitted to multiple healthcare professionals who may analyze the information jointly. Based on the analysis, the one or more healthcare professionals may generate a recommendation based on the transmitted information. The recommendation may include the mental competency of the user. The recommendation may also include a treatment plan. Afterblock 304 is complete, themethod 300 may proceed to block 306. - At
block 306, the wellness assessmentbehavioral health kiosk 10 may receive the recommendation generated inblock 304. The recommendation generated inblock 304 may be transmitted to the wellness assessmentbehavioral health kiosk 10 using, for example, a computer located near the healthcare professional. One of ordinary skill in the art would readily recognize that any device capable of transmitting such information may transmit the recommendation. The recommendation may be transmitted over a network, such asnetwork 118. Afterblock 306 is completed, themethod 300 may continue to block 308. - At
block 308, the wellness assessmentbehavioral health kiosk 10 may output the recommendation received inblock 306. The output may presented to the user who input information into the wellness assessmentbehavioral health kiosk 10. Alternatively, or additionally, the output may be presented to a third party. As described above, the outputted recommendation may include a course of treatment. Afterblock 308 is complete, themethod 300 may end. - Another aspect of the present application relates to a method for treating a behavioral disorder in a subject in need thereof. The method includes the steps of: prompting the subject with at least one question on a display of a system for assessment of a behavioral disorder of the subject, wherein the system comprises the display, an input device, a processer and a database; recording at least one response to the system, wherein the at least one response comprises a long-form answer; analyzing the at least one response by at least one health professional; determining by the at least one health professional, based on the at least one response, the behavioral disorder of the subject; and incorporating the behavioral disorder of the subject into an electronic health record associated with the subject. The method further comprises administering to the subject at least one treatment effective for the behavioral disorder.
- In some embodiments, the method further comprises the step of retrieving a medical history of the subject from a database and accepting the at least one attribute from the medical history for the determination of the behavioral disorder of the subject. In some embodiments, the method further comprises the step of presenting one or more questions about the medical history of the subject and receiving responses to the one or more questions about the medical history of the subject for the determination of the behavioral disorder of the subject.
- In some embodiments, the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history triggers an automatic alert for review by the at least one health professional if the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history matches an alert event in an alert database.
- In some embodiments, the method comprises analyzing the at least one response by two health professionals. In some further embodiments, the at least one health professional is a mental health professional. In still further embodiments, the mental health professional is a psychiatrist. In other further embodiments, the at least one health professional is a physician. In yet other embodiments, the two health professionals are a physician and a mental health professional.
- In particular embodiments, the method further comprises the step of converting the at least one response into an assessment score based on a matrix.
- There are numerous art-known therapeutic regimes for the treatment of behavioral disorders. In certain embodiments, the therapeutic regimes can include treatment with pharmacological compounds that modulate the brain's serotonin and/or norepinephrine systems. Such pharmacological compounds include, but are not limited to, tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRI), selective norepinephrine reuptake inhibitors (SNRI), and serotonin antagonist and reuptake inhibitors (SARI). Specific exemplary pharmacological compounds include amitriptyline (ELAVIL™), clomipramine (ANAFRANIL™), desipramine (NORPRAMIN™), doxepin (SINEQUANT™), imipramine (TOFRANIL™), nortriptyline (PAMELORT™), protriptyline (VIVACTIL™), fluoxetine (PROZAC™), fluvoxamine (LUVOX™), paroxetine (PAXIL™), sertaline (ZOLOFT™), citalopram (CELEXA™), escitalopram oxalate (LEXAPRO™) duloxetine (CYMBALTA™) venlafaxine (EFFEXOR™), mirtazapine (REMERON™), nefazodone (SERZONE™), and desyrel (TRAZODONET™). The foregoing pharmacological compounds can be used singly or in any combination. The foregoing list of exemplary compounds is not exhaustive of those known in the art, which can be used in accordance with the present application.
- Non-pharmacological therapeutic regimes include, for example, psychotherapy, including exposure-based psychotherapy, cognitive psychotherapy, and psycho-dynamically oriented psychotherapy; electroconvulsive therapy (ECT).
- The above description is for the purpose of teaching the person of ordinary skill in the art how to practice the object of the present application, and it is not intended to detail all those obvious modifications and variations of it which will become apparent to the skilled worker upon reading the description. It is intended, however, that all such obvious modifications and variations be included within the scope of the present application, which is defined by the following claims. The aspects and embodiments are intended to cover the components and steps in any sequence which is effective to meet the objectives there intended, unless the context specifically indicates the contrary.
Claims (18)
1. A method for assessment of a mental state of a human subject, the method comprising:
prompting the subject with at least one question on a display of a system for assessment of the mental state of the subject;
recording at least one response to the at least one question in the system;
calculating an assessment score based on the at least one response, wherein the at least one response comprises a long form answer;
determining by at least one health professional, based on the at least one response and/or the assessment score, the mental state of the subject;
incorporating the mental state of the subject into an electronic health record associated with the subject;
retrieving a medical history of the subject from a database and accepting at least one attribute from the medical history for the determination of the mental state of the subject, and/or
presenting one or more questions about the medical history of the subject and receiving at least one response to the one or more questions about the medical history of the subject for the determination of the mental state of the subject,
wherein the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history triggers the system to present an automatic alert for review by the at least one health professional if the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history matches an alert event in an alert database; and
wherein the at least one response comprises a long-form answer and wherein the system comprises the display, an input device, a processer, a database and a matrix for converting the at least one response to an assessment score.
2. The method of claim 1 , comprising analyzing the at least one response by two health professionals.
3. The method of claim 2 , wherein at least one health professional is a mental health professional.
4. The method of claim 2 , wherein at least one health professional is a physician.
5. The method of claim 2 , wherein the two health professionals are a physician and a mental health professional.
6. The method of claim 5 , wherein the physician is a primary care physician of the subject.
7. The method of claim 1 , wherein the determined mental state is a behavioral disorder selected from the group consisting of depression, substance abuse, risk for bipolar disorder, and post-traumatic stress disorder.
8. The method of claim 1 , further comprising: collecting demographic information regarding the subject.
9. The method of claim 1 , wherein the mental state of the subject is determined based on the assessment score.
10. The method of claim 1 , wherein a depression severity questionnaire is presented to the subject when the assessment score indicates the presence of depression in the subject.
11. A method for treating a behavioral disorder in a subject in need thereof, the method comprising:
prompting the subject with at least one question on a display of a system for assessment of a behavioral disorder of the subject;
recording at least one response to the system, wherein the at least one response comprises a long-form answer;
analyzing the at least one response by at least one health professional;
determining by the at least one health professional, based on the at least one response, the behavioral disorder of the subject; and
incorporating the behavioral disorder of the subject into an electronic health record associated with the subject;
retrieving a medical history of the subject from a database and accepting at least one attribute from the medical history for the determination of the behavioral disorder of the subject, and/or
presenting one or more questions about the medical history of the subject and receiving at least one response to the one or more questions about the medical history of the subject for the determination of the behavioral disorder of the subject,
wherein the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history triggers the system to present an automatic alert for review by the at least one health professional if the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history matches an alert event in an alert database; and
administering to the subject at least one treatment effective for the behavioral disorder, wherein the system comprises the display, an input device, a processer and a database.
12. The method of claim 11 , comprising analyzing the at least one response by two health professionals.
13. The method of claim 12 , wherein at least one health professional is a mental health professional.
14. The method of claim 12 , wherein at least one health professional is a physician.
15. The method of claim 12 , wherein the two health professionals are a physician and a mental health professional.
16. The method of claim 11 , further comprising: converting the at least one response into an assessment score based on a matrix.
17. A system for assessment of a mental state of a subject, the system comprising:
a computer-readable memory, the computer-readable memory configured to store computer-executable instructions;
an input device configured to receive an input from the subject; and
a processor configured to execute the computer-executable instructions, the computer-executable instructions comprising:
prompting the subject with at least one question in a system for assessment of mental state on a display;
recording at least one response to the at least one assessment, wherein the at least one response comprises a long-form answer;
converting the at least one response into at least one assessment score;
generating an output comprising the at least one assessment score for assessment of the mental state of the subject by at least one health professional,
retrieving a medical history of the subject from a database and accepting at least one attribute from the medical history for the determination of the mental state of the subject, and/or
presenting one or more questions about the medical history of the subject and receiving at least one response to the one or more questions about the medical history of the subject for the determination of the mental state of the subject,
wherein the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history triggers the system to present an automatic alert for review by the at least one health professional if the at least one attribute from the medical history and/or the at least one response to the one or more questions about the medical history matches an alert event in an alert database; and
generating a report of the mental state of the subject based on the assessment by the at least one health professional and incorporating the report into an electronic health record associated with the subject.
18. The system of claim 17 , wherein the computer-executable instructions further comprise: collecting demographic information regarding the user.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/030,213 US20180310866A1 (en) | 2016-10-17 | 2018-07-09 | Mental health assessment method and kiosk-based system for implementation |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/295,489 US10244975B2 (en) | 2016-10-17 | 2016-10-17 | Mental health assessment method and kiosk-based system for implementation |
| US16/030,213 US20180310866A1 (en) | 2016-10-17 | 2018-07-09 | Mental health assessment method and kiosk-based system for implementation |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/295,489 Continuation US10244975B2 (en) | 2016-10-17 | 2016-10-17 | Mental health assessment method and kiosk-based system for implementation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20180310866A1 true US20180310866A1 (en) | 2018-11-01 |
Family
ID=61902416
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/295,489 Active US10244975B2 (en) | 2016-10-17 | 2016-10-17 | Mental health assessment method and kiosk-based system for implementation |
| US16/030,213 Abandoned US20180310866A1 (en) | 2016-10-17 | 2018-07-09 | Mental health assessment method and kiosk-based system for implementation |
| US16/036,585 Abandoned US20180325439A1 (en) | 2016-10-17 | 2018-07-16 | Mental health assessment method and kiosk-based system for implementation |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/295,489 Active US10244975B2 (en) | 2016-10-17 | 2016-10-17 | Mental health assessment method and kiosk-based system for implementation |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US16/036,585 Abandoned US20180325439A1 (en) | 2016-10-17 | 2018-07-16 | Mental health assessment method and kiosk-based system for implementation |
Country Status (1)
| Country | Link |
|---|---|
| US (3) | US10244975B2 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10748644B2 (en) | 2018-06-19 | 2020-08-18 | Ellipsis Health, Inc. | Systems and methods for mental health assessment |
| US11120895B2 (en) | 2018-06-19 | 2021-09-14 | Ellipsis Health, Inc. | Systems and methods for mental health assessment |
| US20220139562A1 (en) * | 2020-07-10 | 2022-05-05 | Modality.Ai, Inc. | Use of virtual agent to assess psychological and medical conditions |
| US12300227B2 (en) | 2021-04-19 | 2025-05-13 | Modality.AI | Customizing computer generated dialog for different pathologies |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180329984A1 (en) * | 2017-05-11 | 2018-11-15 | Gary S. Aviles | Methods and systems for determining an emotional condition of a user |
| US10410655B2 (en) * | 2017-09-18 | 2019-09-10 | Fujitsu Limited | Estimating experienced emotions |
| MY209608A (en) * | 2019-04-10 | 2025-07-24 | Genting Taurx Diagnostic Centre Sdn Bhd | Adaptive neurological testing method |
| WO2021046553A1 (en) * | 2019-09-08 | 2021-03-11 | Kevin Rogers | Systems and methods for diagnosing and treating mood disorders |
| AU2021231069A1 (en) * | 2020-03-06 | 2022-10-13 | Integrated Mental Health Technologies, LLC | Interactive system for improved mental health |
| CN111481182B (en) * | 2020-04-09 | 2023-05-09 | 西南政法大学 | Mental disorder patient risk level judging system |
| CN111466929B (en) * | 2020-04-09 | 2023-05-09 | 西南政法大学 | Violent mental disorder patient prevention system based on risk level judgment |
| CN111568445B (en) * | 2020-05-15 | 2023-02-07 | 首都医科大学 | Delirium risk monitoring method and system based on delirium dynamic prediction model |
| JP7410516B2 (en) * | 2020-06-19 | 2024-01-10 | 国立大学法人北海道大学 | Parent and child health management system, parent and child health analysis device, and parent and child health management method |
| CN116096301A (en) * | 2020-09-08 | 2023-05-09 | 泰尔茂株式会社 | Program, information processing apparatus, and information processing method |
| CN112766898B (en) * | 2021-01-14 | 2023-12-12 | 中南大学湘雅医院 | Neuropsychiatric assessment scale information management system and management method |
| CN119811600A (en) * | 2025-03-12 | 2025-04-11 | 四川才子软件信息网络有限公司 | Student psychological interview auxiliary method and system based on AI big model |
| CN120413048B (en) * | 2025-07-01 | 2025-08-29 | 中国人民解放军海军军医大学 | A method for generating prompts for assessing patients' post-traumatic stress symptoms |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130060580A1 (en) * | 2011-09-06 | 2013-03-07 | A. Bradley Chapman | Automated System for Monitoring Mental Status of Individuals Receiving Outpatient Mental Health Treatment |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6022315A (en) | 1993-12-29 | 2000-02-08 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system including network access |
| AU2001268156B2 (en) | 2000-06-02 | 2006-11-02 | Optuminsight Life Sciences, Inc. | Method and system for health assessment and monitoring |
| EP2109055A1 (en) | 2008-04-11 | 2009-10-14 | Universiteit Maastricht | Portable psychological monitoring device |
| US20110231208A1 (en) | 2008-12-17 | 2011-09-22 | The Johns Hopkins University | System and method for patient self-assessment or treatment compliance |
| US20140114680A1 (en) | 2009-11-12 | 2014-04-24 | RedBrick Health Corporation | Interactive health assessment |
| US20110229867A1 (en) * | 2010-03-19 | 2011-09-22 | Joseph William Gough | System and method of administrating instructions to a recipient of medical treatment |
| US8986014B2 (en) | 2012-04-19 | 2015-03-24 | Brian Murray | Evidence-based, neuro-congnitive testing methodology, protocols and systems |
| US10909216B2 (en) | 2014-05-07 | 2021-02-02 | SkyTherapist, Inc. | Virtual mental health platform |
-
2016
- 2016-10-17 US US15/295,489 patent/US10244975B2/en active Active
-
2018
- 2018-07-09 US US16/030,213 patent/US20180310866A1/en not_active Abandoned
- 2018-07-16 US US16/036,585 patent/US20180325439A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130060580A1 (en) * | 2011-09-06 | 2013-03-07 | A. Bradley Chapman | Automated System for Monitoring Mental Status of Individuals Receiving Outpatient Mental Health Treatment |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10748644B2 (en) | 2018-06-19 | 2020-08-18 | Ellipsis Health, Inc. | Systems and methods for mental health assessment |
| US11120895B2 (en) | 2018-06-19 | 2021-09-14 | Ellipsis Health, Inc. | Systems and methods for mental health assessment |
| US11942194B2 (en) | 2018-06-19 | 2024-03-26 | Ellipsis Health, Inc. | Systems and methods for mental health assessment |
| US12230369B2 (en) | 2018-06-19 | 2025-02-18 | Ellipsis Health, Inc. | Systems and methods for mental health assessment |
| US20220139562A1 (en) * | 2020-07-10 | 2022-05-05 | Modality.Ai, Inc. | Use of virtual agent to assess psychological and medical conditions |
| US12300227B2 (en) | 2021-04-19 | 2025-05-13 | Modality.AI | Customizing computer generated dialog for different pathologies |
Also Published As
| Publication number | Publication date |
|---|---|
| US20180103885A1 (en) | 2018-04-19 |
| US10244975B2 (en) | 2019-04-02 |
| US20180325439A1 (en) | 2018-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10244975B2 (en) | Mental health assessment method and kiosk-based system for implementation | |
| WO2018074996A1 (en) | Mental health assessment method and kiosk-based system for implementation | |
| Henrich et al. | A randomized clinical trial of mindfulness-based cognitive therapy for women with irritable bowel syndrome—Effects and mechanisms. | |
| Tapert et al. | Neural response to alcohol stimuli in adolescents with alcohol use disorder | |
| Prakash et al. | Protocol for a randomized controlled trial of mindfulness-based stress reduction to improve attentional control in older adults (HealthyAgers trial) | |
| Chen et al. | Considerations in children and adolescents related to coronavirus disease 2019 (COVID-19) | |
| Troisi | Mental health and well-being: clinical applications of Darwinian psychiatry | |
| Tanlamai et al. | Use of daily posture and activity tracking to assess sedentary behavior, toss-and-turns, and sleep duration of independently living Thai seniors | |
| Hellqvist | Self-management support to handle everyday life with Parkinson´ s disease | |
| Kaplan | RISK FACTORS | |
| Fymat | Tourette's syndrome: II. Diagnosis and Symptoms Management | |
| Silver et al. | North American brain injury society | |
| Clow | Management of adolescent depression in the primary care setting: An educational program for providers | |
| Weintraub et al. | North American Brain Injury Society | |
| Jones | The Effects of Sleep Impairment on Perceived Prospective Memory in Veterans with Parkinson’s Disease | |
| Chen | Traumatic Brain Injury in the Chinese American Adolescent Population: A Critical Analysis of the Literature | |
| Sibley et al. | BIBLIOGRAFIA ADHD MARZO 2022 | |
| Stevenson et al. | Assessment in rehabilitation psychology. | |
| Snyder | The Relationship Between Anxious Arousal, Worry, Executive Functions, and Effortful Control in Adults With Generalized Anxiety Disorder | |
| Sørensen et al. | Strategies that shape perception | |
| Zelazny et al. | Shape-color associations are mediated by stereotypicality | |
| Apreutesei et al. | Intersection Between Frailty, Sex, Duration of Antidepressant Medication Exposure, and the Development of Dementia | |
| Giampietri | in Infants at High Risk for Cerebral | |
| Nikolai et al. | INVITED SYMPOSIUM | |
| Morelli et al. | Effectiveness of Trauma-Focused Cognitive Behavioral Therapy for Youth with Complex Trauma Exposure: A Systematic Review |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| AS | Assignment |
Owner name: MOREHOUSE SCHOOL OF MEDICINE, GEORGIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WRENN, GLENDA;REEL/FRAME:047534/0458 Effective date: 20181115 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |